omeprazole has been researched along with Gastritis in 388 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Excerpt | Relevance | Reference |
---|---|---|
" pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone." | 9.24 | Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. ( Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY, 2017) |
"To date, guidelines on the impact and value of atropine combined with omeprazole in the treatment of acute gastritis have not been well established or well defined." | 9.12 | The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis. ( Chen, H; Lin, X; Lin, YN, 2021) |
"To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 9.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
" pylori) gastritis in children by the adjunction of omeprazole (OAC) was studied." | 9.12 | Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. ( Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y, 2007) |
" This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)." | 9.11 | Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004) |
"Both sucralfate and rabeprazole therapies are effective treatment options in the patients with alkaline gastritis when compared with observation." | 9.10 | Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. ( Cammarota, G; Candelli, M; Cremonini, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Nista, EC; Santarelli, L, 2003) |
"Thirty-eight children with Helicobacter pylori gastritis diagnosed by histopathology, and/or bacteriological culture were treated with omeprazole, amoxicillin and clarithromycin." | 9.09 | Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. ( Finkel, Y; Sandstedt, B; Tirén, U, 1999) |
"The aim of this multicenter prospective, randomized, double-blind study was to assess the efficacy of the combination of omeprazole, amoxicillin, and clarithromycin (OAC) for the treatment of Helicobacter pylori gastritis in children." | 9.09 | Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. ( Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P, 2001) |
"Satisfactory antral biopsies were obtained from 119 duodenal ulcer patients before and after 4 wk of therapy with lansoprazole, ranitidine, or placebo." | 9.08 | The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. ( Atkinson, BF; Brightman, SA; Jhala, NC; McFarland, MM; Morale, B; Rubin, W, 1995) |
"Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers." | 9.08 | Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. ( Blum, AL; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B; Verdú, EF, 1996) |
" pylori from the gastric mucosa, and omeprazole frequently is used for the treatment of duodenal ulcer disease, prompting the interest to investigate rigorously the combination of clarithromycin and omeprazole for eradicating H." | 9.08 | Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. ( Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E, 1996) |
"In this randomized multicentre study, 267 duodenal ulcer patients were treated for 2 weeks with omeprazole 40 bid (Group A) or 20 mg bid (Group B), respectively, and with amoxycillin 0." | 9.08 | Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. ( Annibale, B; Bordi, C; Cesana, B; Damilano, I; Franceschi, M; Maconi, G; Pilato, FP, 1997) |
" pylori and with gastro-oesophageal reflux disease we investigated the gastritis parameters in antral and corpus mucosa before and after 2, 6 and 12 months of treatment with 15 or 30 mg lansoprazole or 20 mg omeprazole/day." | 9.08 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. ( Alexandridis, T; Meining, A; Schmitz, JM; Seifert, E; Stolte, M, 1998) |
" pylori-infected duodenal ulcer patients we investigated the gastritis parameters in antral and corpus mucosa before treatment, after 6 and 12 months of therapy, and 6 months after termination of treatment with 15 mg lansoprazole or 150 mg ranitidine/day." | 9.08 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. ( Kiel, G; Meining, A; Stolte, M, 1998) |
"Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis." | 9.08 | Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998) |
"Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 9.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
"In a controlled, prospective, randomized trial, 10 patients with Helicobacter pylori positive gastritis were treated either with triple therapy (tetracycline, ornidazole, bismuth subcitrate; T, Or, CBS), or omeprazole/CBS (O/CBS) to test the eradication rate of each treatment, its effect on gastritis and meal stimulated gastrin release." | 9.07 | [Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study]. ( Bertschinger, P; Brunner, J; Flury, R; Häcki, WH; Jost, R; Lammer, F, 1992) |
"This study set out to investigate the effects of omeprazole or ranitidine on the progression of antral gastritis and Helicobacter pylori in patients with active duodenal ulcer." | 9.07 | Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. ( Branicki, FJ; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM, 1991) |
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia." | 7.76 | Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010) |
"The present study was designed to investigate the effect of 7,8-dimethoxycoumarin (DMC) isolated from ethyl acetate extract of Citrus decumana peels on gastritis in rats." | 7.76 | Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats. ( Bali, M; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S, 2010) |
" This study evaluated the inhibitory action of apigenin-7-O-beta-D-glucuronopyranoside (AGC), apigenin, and omeprazole on reflux oesophagitis and gastritis in rats." | 7.73 | The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. ( Bai, KL; Choi, HJ; Ham, I; Jeong, JH; Min, YS; Park, SY; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2005) |
"To confirm the immediate-type mechanism of recurrent anaphylactic reactions to the repeated administration of omeprazole using skin testing and to enable safe administration of the drug after successful oral desensitization." | 7.73 | Anaphylaxis to omeprazole: diagnosis and desensitization protocol. ( Confino-Cohen, R; Goldberg, A, 2006) |
"This study evaluated the inhibitory action of luteolin-7-O-beta-D-glucuronopyranoside, luteolin which was isolated from Salix gilgiana leaves, and omeprazole on reflux esophagitis and gastritis in rats." | 7.73 | The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats. ( Bai, KL; Ham, I; Kim, JH; Lee, YJ; Min, YS; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2006) |
"Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk." | 7.72 | Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004) |
" pylori infection on gastritis, enterochromaffin-like cell density and hyperplasia, mucosal atrophy and serum gastrin in patients with gastric hypersecretion (basal acid output gt; 15 mmol/h) with either hypergastrinemia (Zollinger-Ellison syndrome) or normal gastrin (non-Zollinger-Ellison syndrome) before and during long-term treatment with lansoprazole." | 7.71 | Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. ( Haber, MM; Hirschowitz, BI, 2001) |
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6." | 7.70 | Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000) |
"An antibiotic combination that includes a proton pump inhibitor such as omeprazole and an antibiotic such as clarithromycin is likely to become the new standard regimen for treatment of Helicobacter pylori gastritis because this combination is extremely effective and very well tolerated." | 7.69 | Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. ( Getz, HD; Metz, DC, 1995) |
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 7.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
" The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0." | 7.69 | [Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994) |
" pylori represents an important factor for the progression of fundic gastritis and the development of argyrophil cell hyperplasia during long-term treatment with lansoprazole." | 7.69 | Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. ( Arnold, R; Brunner, G; Eissele, R; Simon, B; Solcia, E, 1997) |
"To evaluate the efficacy of one-week therapy with omeprazole, clarithromycin and amoxycillin in eradicating Helicobacter pylori and healing duodenal ulcer." | 7.69 | [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. ( Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M, 1997) |
"A marked increase in body gastritis was observed in H pylori infected individuals during long term treatment with the proton pump inhibitor lansoprazole." | 7.69 | Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. ( Berstad, A; Berstad, AE; Brandtzaeg, P; Hatlebakk, JG; Maartmann-Moe, H, 1997) |
"Long-term omeprazole therapy in humans results in moderate hypergastrinemia and a significant argyrophil cell hyperplasia, which are correlated to the grade of corpus gastritis." | 7.68 | Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. ( Brunner, G; Creutzfeldt, W; Lamberts, R; Solcia, E; Strüber, HG, 1993) |
"Twenty-one patients with endoscopically confirmed duodenal ulceration, who had failed to heal with an H2-antagonist, were given omeprazole 20 mg o." | 7.68 | Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. ( Daw, MA; Deegan, P; Leen, E; O'Moráin, C, 1991) |
"A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole." | 7.68 | Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991) |
" HP was eradicated by combined treatment with high-dose omeprazole (2 x 40 mg) and amoxicillin (2 x 1,000 mg; n = 27) administered for 10 days (OME + AMX); alternatively, patients were treated with omeprazole monotherapy (OME) using the same dosage (n = 25)." | 6.68 | Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. ( Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Ruckdeschel, G; Sommer, A; Weingart, J, 1995) |
"Treatment with omeprazole plus amoxicillin or clarithromycin resulted in encouraging Helicobacter pylori cure rates in pilot and controlled studies." | 6.68 | High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. ( Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M, 1995) |
" Thus, a true dose-response relationship exists between omeprazole and treatment success." | 6.68 | Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. ( Beker, JA; Dekker, CP; Farley, A; Jönsson, A; Klör, HU; Labenz, J, 1997) |
"Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 5.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
"Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium." | 5.31 | [Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000) |
"It is used for treatment of gastroduodenal ulcers, reflux oesophagitis and Zollinger Ellison's syndrome." | 5.29 | [The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis]. ( Drábek, J; Hanika, J; Soucková, A; Vejvalka, J; Zelenková, J; Zeman, V, 1993) |
"Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 5.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
"Omeprazole treatment produces lower intragastric pH values 4 weeks after cure of Helicobacter pylori infection than before." | 5.29 | Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. ( Armstrong, D; Blum, AL; Börsch, G; Idström, JP; Labenz, J; Stolte, M; Verdú, EF, 1996) |
"Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter." | 5.28 | Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991) |
" pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone." | 5.24 | Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. ( Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY, 2017) |
" pylori-related chronic gastritis who were randomly provided either 10-day omeprazole-based triple therapy (OM-triple; omeprazole 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1 g twice daily) or 10-day B-quadruple therapy (OM-triple + bismuth subcitrate 120 mg four times daily)." | 5.24 | Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China. ( Chen, C; Chen, S; Ding, J; Du, Q; Huang, Z; Jiang, Y; Li, J; Li, W; Lin, Z; Meng, L; Si, J; Wang, L; Wu, L; Ye, B, 2017) |
" pylori infection was statistically significantly dependent on omeprazole dosage, CYP2C19 genotype, age, gastritis status, and H." | 5.15 | Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. ( Chern, HD; Lin, BR; Lin, CJ; Shun, CT; Wang, HL; Wang, TH; Yang, JC, 2011) |
"Ninety-one Helicobacter pylori-positive patients with nonulcer dyspepsia were randomized to receive either lansoprazole, amoxicillin, and clarithromycin or lansoprazole and placebo." | 5.12 | Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study. ( Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC, 2006) |
" Intention-to-treat analysis revealed a trend to a higher healing rate of lymphocytic gastritis 3 months after triple therapy compared with omeprazole/placebo (83." | 5.12 | Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. ( Bayerdörffer, E; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neuber, F; Rappel, S; Seitz, G; Stolte, M, 2006) |
"To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 5.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
" pylori) gastritis in children by the adjunction of omeprazole (OAC) was studied." | 5.12 | Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. ( Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y, 2007) |
" This prospective randomised study aimed to investigate whether H pylori eradication can influence gastritis and its sequelae during long term omeprazole therapy for gastro-oesophageal reflux disease (GORD)." | 5.11 | Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. ( Dent, J; Festen, HP; Goldfain, D; Havu, N; Klinkenberg-Knol, EC; Kolkman, JJ; Kuipers, EJ; Lamm, M; Nelis, GF; Snel, P; Walan, A; Zeitoun, P, 2004) |
"Two hundred and forty-three patients received rabeprazole (20 mg or 10 mg) or omeprazole (20 mg) once daily for up to 5 years, for gastro-oesophageal reflux disease and 51% completed the whole 5 year period." | 5.11 | Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. ( Fiocca, R; Jacobs, A; Miller, N; Morocutti, A; Rindi, G; Thjodleifsson, B, 2005) |
" pylori associated gastritis were randomly divided into pantoprazole triple regimen group (pantoprazole 40 mg, amoxicillin 1 g, and metronidazole 400 mg, bid,for 1-week or 2-weeks) and omeprazole triple regimen (omeprazole 20 mg, amoxicillin 1 g, and metronidazole 400 mg, bid, for 1-week or 2-weeks)." | 5.10 | [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection]. ( Cui, M; Hu, F; Jiang, H; Zheng, X, 2002) |
" pylori-positive gastritis or peptic ulcers were randomly assigned to receive 30 mg lansoprazole twice daily (LAC group), 10 mg rabeprazole twice daily (RAC20 group), or 20 mg rabeprazole twice daily (RAC40 group), with 1000 mg amoxicillin twice daily and 400 mg clarithromycin twice daily for 1 week." | 5.10 | Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan. ( Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM, 2003) |
"Both sucralfate and rabeprazole therapies are effective treatment options in the patients with alkaline gastritis when compared with observation." | 5.10 | Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. ( Cammarota, G; Candelli, M; Cremonini, F; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Nista, EC; Santarelli, L, 2003) |
"Thirty-eight children with Helicobacter pylori gastritis diagnosed by histopathology, and/or bacteriological culture were treated with omeprazole, amoxicillin and clarithromycin." | 5.09 | Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. ( Finkel, Y; Sandstedt, B; Tirén, U, 1999) |
" All patients belong to a low socioeconomic strata, had multifocal atrophic gastritis documented by gastric biopsies, and had been treated previously and unsuccessfully for 2 weeks with bismuth subsalicylate (262 mg four times a day), amoxicillin (500 mg three times a day), and metronidazole (400 mg three times a day)." | 5.09 | Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. ( Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL, 1999) |
" pylori-infected patients with nonulcer dyspepsia to receive twice-daily treatment with 20 mg of omeprazole, 1000 mg of amoxicillin, and 500 mg of clarithromycin for 14 days and 167 such patients to receive identical-appearing placebos; all patients were then followed through regular visits for 12 months." | 5.09 | Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. ( Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N, 1999) |
" pylori-positive patients who had peptic ulcers or reflux oesophagitis were treated for 3 years with either omeprazole (20 mg/day) alone (n=7) or with omeprazole for primary therapy (8 weeks), followed by famotidine (40 mg/day) for maintenance therapy (n=134)." | 5.09 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. ( Mashiba, H; Matsumura, N; Okamoto, S; Sasaki, N; Taniyama, K; Uemura, N; Yamaguchi, S; Yamamoto, S, 2000) |
"Among the 15 patients with hemorrhagic acute gastritis who were randomly allocated to group A (eradication therapy) or group B (Lansoprazole, LPZ), 10 of them started to receive treatment within 1 day after the disease onset." | 5.09 | A short-term eradication therapy for Helicobacter pylori acute gastritis. ( Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T, 2000) |
"The aim of this multicenter prospective, randomized, double-blind study was to assess the efficacy of the combination of omeprazole, amoxicillin, and clarithromycin (OAC) for the treatment of Helicobacter pylori gastritis in children." | 5.09 | Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. ( Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P, 2001) |
"A total of 170 Helicobacter pylori-positive patients with chronic gastritis were randomized to receive one of the following Helicobacter pylori eradication regimens; OAC (omeprazole 20 mg bd, amoxycillin 750 mg bd and clarithromycin 400 mg bd for 1 week) and RAC (rabeprazole 20 mg bd, amoxycillin 750 mg bd and clarithromycin 400 mg bd for 1 week)." | 5.09 | Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan. ( Azuma, T; Dojo, M; Kuriyama, M; Muramatsu, A; Ohtani, M; Saito, T, 2001) |
" Men between 55 and 65 years of age with a gastric cancer phenotype of Helicobacter pylori gastritis are randomized to receive a 7 day course of omeprazole 2 X 20mg, clarithromycin 2 X 500mg, and amoxicillin 2 X 1g for 7 days, or omeprazole 2 X 20mg plus placebo." | 5.09 | Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). ( Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M, 2001) |
"Satisfactory antral biopsies were obtained from 119 duodenal ulcer patients before and after 4 wk of therapy with lansoprazole, ranitidine, or placebo." | 5.08 | The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. ( Atkinson, BF; Brightman, SA; Jhala, NC; McFarland, MM; Morale, B; Rubin, W, 1995) |
"pylori positive (histology and/or culture) ulcer disease (n = 17; acute ulcer: n = 11) or functional dyspepsia (n = 13) were treated over one week with pantoprazole 40 mg bd, clarithromycin 250 mg bd and metronidazole 400 mg bd." | 5.08 | [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. ( Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B, 1995) |
"Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers." | 5.08 | Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. ( Blum, AL; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B; Verdú, EF, 1996) |
"The combined therapy with amoxycillin, metronidazole, and omeprazole is highly effective in both HP eradication and prevention of duodenal ulcer recurrence." | 5.08 | Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. ( Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L, 1996) |
"Changes in Helicobacter pylori-associated gastritis of the antrum and corpus were investigated in a large number of patients treated with omeprazole, with or without the addition of amoxycillin." | 5.08 | Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics. ( Carlsson, J; Fiocca, R; Rudbäck, A; Solcia, E; Villani, L; Zeijlon, L, 1996) |
" pylori infection in patients with chronic gastritis (CG), duodenal ulcer (DU), and gastric ulcer (GU) after two dual therapies (omeprazole with either amoxycillin or clarithromycin)." | 5.08 | Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. ( Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C, 1996) |
" pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients." | 5.08 | Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997) |
" pylori-associated gastritis were treated with 20 mg omeprazole once daily in the morning, 20 mg omeprazole b." | 5.08 | An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively. ( Bayerdörffer, E; Hele, C; Lehn, N; Mannes, GA; Miehlke, S; Stolte, M, 1997) |
"The purpose of the present study was to examine the association between interleukin-8 (IL-8) in the gastric body due to Helicobacter pylori infection and histological gastritis, as well as elucidating the effect of acid secretion inhibitors on H." | 5.08 | Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. ( Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Oomoto, Y; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S, 1997) |
" pylori-infected patients with endoscopically documented duodenal ulcer either currently or within the past year were randomized to 14 days of (1) lansoprazole, 30 mg bid, plus amoxicillin, 1 gm tid; (2) lansoprazole, 30 mg tid, plus amoxicillin, 1 gm tid; (3) lansoprazole, 30 mg tid alone; or (4) amoxicillin, 1 gm tid alone." | 5.08 | Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. ( Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A, 1996) |
" pylori from the gastric mucosa, and omeprazole frequently is used for the treatment of duodenal ulcer disease, prompting the interest to investigate rigorously the combination of clarithromycin and omeprazole for eradicating H." | 5.08 | Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. ( Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E, 1996) |
" Patients (n = 787) with proved duodenal ulcer disease were randomized to treatment twice daily for 1 week with omeprazole, 20 mg (O), plus either placebo (P) or combinations of two of the following antimicrobials: amoxicillin, 1 gm (A), clarithromycin, 250 or 500 mg (C250, C500), or metronidazole, 400 mg (M)." | 5.08 | Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. ( Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M, 1996) |
"In this randomized multicentre study, 267 duodenal ulcer patients were treated for 2 weeks with omeprazole 40 bid (Group A) or 20 mg bid (Group B), respectively, and with amoxycillin 0." | 5.08 | Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. ( Annibale, B; Bordi, C; Cesana, B; Damilano, I; Franceschi, M; Maconi, G; Pilato, FP, 1997) |
" pylori and with gastro-oesophageal reflux disease we investigated the gastritis parameters in antral and corpus mucosa before and after 2, 6 and 12 months of treatment with 15 or 30 mg lansoprazole or 20 mg omeprazole/day." | 5.08 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. ( Alexandridis, T; Meining, A; Schmitz, JM; Seifert, E; Stolte, M, 1998) |
" pylori-infected duodenal ulcer patients we investigated the gastritis parameters in antral and corpus mucosa before treatment, after 6 and 12 months of therapy, and 6 months after termination of treatment with 15 mg lansoprazole or 150 mg ranitidine/day." | 5.08 | Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. ( Kiel, G; Meining, A; Stolte, M, 1998) |
" pylori-associated gastritis, received seven days of lansoprazole, bismuth, tetracycline and metronidazole after three days of lansoprazole pretreatment." | 5.08 | Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection. ( Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB, 1998) |
"Rabeprazole is a new fast acting proton pump inhibitor that has recently been proven to be effective in the treatment of peptic ulceration and reflux esophagitis." | 5.08 | Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. ( Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D, 1998) |
"Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 5.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
" pylori infection and gastritis were treated with one of the following four regimens: omeprazole 40 mg/day for one week (group A, n = 14); omeprazole 40 mg/day for one week followed by clarithromycin 1 g/day for 2 weeks (group B, n = 26); omeprazole 40 mg/day for one week followed by tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day, both for two weeks (group C, n = 26); and tripotassium dicitrato bismuthate 480 mg/day and clarithromycin 1 g/day for two weeks (group D, n = 22)." | 5.07 | Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. ( Cuccurullo, F; Di Iorio, P; Laterza, F; Mezzetti, A; Neri, M; Seccia, G; Susi, D, 1994) |
"In a controlled, prospective, randomized trial, 10 patients with Helicobacter pylori positive gastritis were treated either with triple therapy (tetracycline, ornidazole, bismuth subcitrate; T, Or, CBS), or omeprazole/CBS (O/CBS) to test the eradication rate of each treatment, its effect on gastritis and meal stimulated gastrin release." | 5.07 | [Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study]. ( Bertschinger, P; Brunner, J; Flury, R; Häcki, WH; Jost, R; Lammer, F, 1992) |
"In an open study, 62 patients with Helicobacter pylori-associated ulcer disease or functional dyspepsia were treated for two weeks with 2 x 20 mg omeprazole preprandially and 4 x 500 mg amoxicillin suspension one hour before meals and at night." | 5.07 | Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori. ( Börsch, G; Gyenes, E; Labenz, J; Rühl, GH, 1992) |
" pylori-associated gastritis were allocated to one of the following four therapeutic schedules: 1) omeprazole 40 mg/d for 4 weeks (n = 13); 2) bismuth subsalicylate (BSS) 3 x 600 mg for 4 weeks (n = 12); 3) omeprazole plus BSS for 4 weeks (n = 13); 4) triple therapy (BSS for 4 weeks, amoxicillin 3 x 750 mg and metronidazole 3 x 400 mg for 10 days) (n = 12)." | 5.07 | The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection. ( Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S, 1991) |
"This study set out to investigate the effects of omeprazole or ranitidine on the progression of antral gastritis and Helicobacter pylori in patients with active duodenal ulcer." | 5.07 | Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. ( Branicki, FJ; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM, 1991) |
" In the treatment of gastric ulcer, analysis of all studies that have compared lansoprazole, a newly developed proton pump inhibitor, and H2-receptor antagonists has shown a statistically significant difference for a higher healing rate with lansoprazole." | 4.78 | Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. ( Florent, C, 1993) |
" pylori culture positive dyspeptic patients (64 patients with peptic ulcer, PU) completed a 2-week treatment with omeprazole, amoxicillin and metronidazole and underwent endoscopy again 6-8 weeks after the end of therapy." | 3.78 | Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection. ( Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C, 2012) |
"Omeprazole is a mainstay of therapy for gastroesophageal reflux disease (GERD) and gastritis, and is increasingly used as an over-the-counter remedy for dyspepsia." | 3.76 | Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. ( Blass, AL; Kohler, JE; Liu, J; Soybel, DI; Tai, K, 2010) |
"The present study was designed to investigate the effect of 7,8-dimethoxycoumarin (DMC) isolated from ethyl acetate extract of Citrus decumana peels on gastritis in rats." | 3.76 | Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats. ( Bali, M; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S, 2010) |
"The authors made an attempt to find a new approach to Helicobacter pylori (HP) eradication in patients with chronic gastritis and peptic ulcer without application of antibiotics, but using melatonin properties instead." | 3.74 | [Antihelicobacter effects of melatonin]. ( Malinovskaia, NK; Parkhomenko, IE; Postnikova, LI; Rapoport, SI; Rybnikova, SN; Zhernakova, NI, 2007) |
"This is our final report on the clinical effectiveness and safety of long-term pantoprazole in patients with severe peptic ulcer or reflux disease during continuous treatment for up to 5 years." | 3.73 | Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. ( Bardhan, KD; Bishop, AE; Luehmann, R; McCaldin, B; Morris, P; Polak, JM; Romanska, HM; Rowland, A; Schaefer-Preuss, S; Thompson, M, 2005) |
" This study evaluated the inhibitory action of apigenin-7-O-beta-D-glucuronopyranoside (AGC), apigenin, and omeprazole on reflux oesophagitis and gastritis in rats." | 3.73 | The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats. ( Bai, KL; Choi, HJ; Ham, I; Jeong, JH; Min, YS; Park, SY; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2005) |
" The patient was also treated with omeprazole (20 mg/day) because of chronic gastritis." | 3.73 | Gastric pH, sevelamer hydrochloride and omeprazole. ( Capitanini, A; Del Corso, C; Gallieni, M; Lupi, A; Osteri, F; Petrone, I; Rossi, A; Straniti, M, 2005) |
"To confirm the immediate-type mechanism of recurrent anaphylactic reactions to the repeated administration of omeprazole using skin testing and to enable safe administration of the drug after successful oral desensitization." | 3.73 | Anaphylaxis to omeprazole: diagnosis and desensitization protocol. ( Confino-Cohen, R; Goldberg, A, 2006) |
"This study evaluated the inhibitory action of luteolin-7-O-beta-D-glucuronopyranoside, luteolin which was isolated from Salix gilgiana leaves, and omeprazole on reflux esophagitis and gastritis in rats." | 3.73 | The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats. ( Bai, KL; Ham, I; Kim, JH; Lee, YJ; Min, YS; Sohn, UD; Song, HJ; Whang, WK; Yim, SH, 2006) |
" pylori infection who had gastritis, duodenal ulcer (DU) or gastric ulcer (GU) received 1 week's triple therapy of lansoprazole 30 g once daily (OD), amoxycillin 250 mg qid and clarithromycin 250 mg tid." | 3.72 | Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection. ( Uthaisaengsook, W, 2003) |
"Six captive cheetahs (Acinonyx jubatus) with severe gastritis diagnosed by gastric endoscopy and mucosal histopathology were treated with omeprazole, metronidazole, and amoxicillin for 3 wk." | 3.72 | Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis. ( Burroughs, R; Lane, E; Lobetti, R, 2004) |
" The patient underwent 7 days of clarithromycin, amoxicillin, and omeprazole treatment for Helicobacter pylori-associated gastritis." | 3.72 | Acute colchicine intoxication during clarithromycin administration. ( Blanche, P; Chauvelot-Moachon, L; Kélaïdi, C; Nazal, EM; Pajot, O; Rollot, F, 2004) |
" pylori infection on gastritis, enterochromaffin-like cell density and hyperplasia, mucosal atrophy and serum gastrin in patients with gastric hypersecretion (basal acid output gt; 15 mmol/h) with either hypergastrinemia (Zollinger-Ellison syndrome) or normal gastrin (non-Zollinger-Ellison syndrome) before and during long-term treatment with lansoprazole." | 3.71 | Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. ( Haber, MM; Hirschowitz, BI, 2001) |
" Therefore, we investigated how the chronic gastritis in mice made hypochlorhydric by either gastrin deficiency or omeprazole treatment modulates epithelial cell function." | 3.71 | Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. ( Ferguson, A; Merchant, JL; Rieder, G; Samuelson, LC; Zavros, Y, 2002) |
"Thirty-eight clinical strains of Helicobacter pylori were isolated from patients with chronic gastritis and gastroduodenal ulceration, and their susceptibility to macrolide antibiotics (roxithromycin, flurithromycin, azithromycin, erythromycin) in combination with proton-pump inhibitors (lansoprazole and omeprazole) and bismuth subcitrate was assayed." | 3.70 | Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. ( Campa, M; Favini, P; Malizia, T; Marchetti, F; Pizzarelli, G; Senesi, S; Tejada, M, 1998) |
"Gastric juice pH, ammonia concentration in gastric juice, serum gastrin level, and grade of gastritis in accordance with the Sydney System were determined for patients with gastric ulcer (GU) and duodenal ulcer (DU) before and after treatment with lansoprazole and amoxicillin, and results were compared with those of H." | 3.70 | Effect of Helicobacter pylori infection on gastric juice pH. ( Arai, H; Baba, S; Furuta, T; Futami, H; Hanai, H; Kajimura, M; Kaneko, E; Takashima, M, 1998) |
" pylori strain (34 duodenal ulcer and 37 nonulcer dyspepsia) received omeprazole 40 mg o." | 3.70 | Weekend therapy for the treatment of Helicobacter pylori infection. ( Agosti, R; Bocus, P; Caletti, G; Grigioni, WF; Mazzoni, C; Orcioni, GF; Paparo, GF; Poli, L; Sottili, S; Togliani, T; Tucci, A, 1998) |
"One hundred eight patients with cultured H pylori-positive gastritis or peptic ulcer were treated with three regimens: quadruple treatment without proton pump inhibitors (n = 25), dual treatment with omeprazole and amoxicillin (INN, amoxicilline) (n = 26), and triple treatment with omeprazole, amoxicillin, and clarithromycin (n = 57)." | 3.70 | CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. ( Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y, 1999) |
" pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk." | 3.70 | The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000) |
" We report data from patients with refractory reflux esophagitis who were undergoing maintenance therapy with >/=20 mg omeprazole daily for a mean period of 6." | 3.70 | Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. ( Dent, J; Frame, MH; Havu, N; Klinkenberg-Knol, EC; Lloyd, D; Mitchell, B; Nelis, F; Prichard, P; Romàn, J; Snel, P; Walan, A, 2000) |
" Given the histology and the fact that rapid urease test results were positive, chronic active gastritis with H." | 3.70 | Iron-deficiency anemia associated with Helicobacter pylori gastritis. ( Imai, T; Konno, M; Muraoka, S; Takahashi, M, 2000) |
" pylori lipopolysaccharide-induced acute gastritis to study the effect of antiulcer agents, omeprazole and sucralfate, on the course of mucosal inflammatory responses by analyzing the interplay between the extent of epithelial cell apoptosis and the mucosal expression of endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-alpha), and the activity of constitutive (cNOS) and inducible (NOS-2) nitric oxide synthase." | 3.70 | Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate. ( Piotrowski, J; Slomiany, A; Slomiany, BL, 2000) |
" pylori with omeprazole and amoxicillin, the skin changes, gastric complaints, and proteinuria disappeared." | 3.69 | Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. ( Borchard, F; Goerz, G; Megahed, M; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F, 1995) |
" pylori testing in patients on profound acid suppressive therapy should be performed on combined corpus and antral specimens, and 2) that omeprazole therapy leads to a strong increase in corpus gastritis, which may explain the observed development of corpus atrophy in a substantial number of patients after several years of continuous acid suppressive treatment." | 3.69 | Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. ( Bloemena, E; Hazenberg, HJ; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Meuwissen, SG; Peña, AS; Uyterlinde, AM, 1995) |
"An antibiotic combination that includes a proton pump inhibitor such as omeprazole and an antibiotic such as clarithromycin is likely to become the new standard regimen for treatment of Helicobacter pylori gastritis because this combination is extremely effective and very well tolerated." | 3.69 | Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. ( Getz, HD; Metz, DC, 1995) |
" 33 patients with primary gastric low-grade MALT lymphoma associated with H pylori gastritis were treated with omeprazole (120 mg daily) and amoxycillin (2." | 3.69 | Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. ( Bayerdörffer, E; Eidt, S; Lehn, N; Neubauer, A; Rudolph, B; Stolte, M; Thiede, C, 1995) |
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 3.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
"These findings indicate that (1) peptic esophagitis was a common cause of chronic abdominal pain in pediatric patients and (2) omeprazole was effective in the treatment of esophagitis in children and adolescents that was resistant to high-dose histamine2-receptor antagonists." | 3.69 | Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. ( Kane, R; Karjoo, M, 1995) |
" The patient, who was being treated with digitoxin for heart failure, reported having taken up to four digitoxin tablets (0." | 3.69 | [Reversible thrombocytopenia due to digitoxin overdose]. ( Kirch, W; Krappweis, J; Petereit, G; Schentke, KU, 1994) |
"Bacterial overgrowth of the small intestine commonly occurs in association with hypochlorhydria caused by atrophic gastritis or during treatment with omeprazole." | 3.69 | Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. ( Golner, B; Kowdley, KV; Pedrosa, MC; Perrone, G; Russell, RM; Saltzman, JR; Sepe, T, 1994) |
" pylori represents an important factor for the progression of fundic gastritis and the development of argyrophil cell hyperplasia during long-term treatment with lansoprazole." | 3.69 | Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. ( Arnold, R; Brunner, G; Eissele, R; Simon, B; Solcia, E, 1997) |
"To evaluate the efficacy of one-week therapy with omeprazole, clarithromycin and amoxycillin in eradicating Helicobacter pylori and healing duodenal ulcer." | 3.69 | [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. ( Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M, 1997) |
"A marked increase in body gastritis was observed in H pylori infected individuals during long term treatment with the proton pump inhibitor lansoprazole." | 3.69 | Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. ( Berstad, A; Berstad, AE; Brandtzaeg, P; Hatlebakk, JG; Maartmann-Moe, H, 1997) |
" Thirty-two consecutive patients (suffering from either peptic ulcer or nonulcer dyspepsia) with Helicobacter pylori infection received omeprazole (40 mg) + bismuth subcitrate (240 mg x 4) + amoxicillin suspension (2000 mg x 4) + metronidazole (500 mg x 4), for only one day." | 3.68 | One-day therapy for treatment of Helicobacter pylori infection. ( Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O, 1993) |
"Long-term omeprazole therapy in humans results in moderate hypergastrinemia and a significant argyrophil cell hyperplasia, which are correlated to the grade of corpus gastritis." | 3.68 | Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. ( Brunner, G; Creutzfeldt, W; Lamberts, R; Solcia, E; Strüber, HG, 1993) |
"Twenty-one patients with endoscopically confirmed duodenal ulceration, who had failed to heal with an H2-antagonist, were given omeprazole 20 mg o." | 3.68 | Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis. ( Daw, MA; Deegan, P; Leen, E; O'Moráin, C, 1991) |
"A double-blind study was conducted to compare gastric ulcer healing time in nontreated dogs with that in dogs treated with either cimetidine or omeprazole." | 3.68 | Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs. ( Bright, RM; DeNovo, RC; Jenkins, CC; Patton, CS; Rohrbach, BW, 1991) |
"Biopsies from the stomachs (antrum and corpus) of 201 patients with peptic ulcers or reflux oesophagitis were retrospectively investigated for the effect of treatment with omeprazole on the elimination of Helicobacter pylori (HP) and on gastritis." | 3.68 | Elimination of Helicobacter pylori under treatment with omeprazole. ( Bethke, B; Stolte, M, 1990) |
"Gastritis was assessed according to the updated Sydney classification for activity, chronic inflammation, gastric glandular atrophy, intestinal metaplasia, and H." | 2.74 | Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. ( Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA, 2009) |
"pylori decreases gastric cancer risk, using preneoplastic conditions as surrogate markers." | 2.71 | Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Johnstone, I; Ley, C; Mohar, A; Parsonnet, J, 2004) |
"Esomeprazole has higher oral bioavailability and increased antimicrobial activity against Helicobacter pylori than omeprazole." | 2.71 | Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study. ( Anagnostopoulos, GK; Arvanitidis, D; Kostopoulos, P; Margantinis, G; Tsiakos, S, 2004) |
" A therapeutical scheme (omeprazole, metronidazole, amoxicilline) obtained a further pathogenetic substantiation of B type CG patient treatment with additional antioxidant vitamin E use at the dosage of 300 mg/day for three weeks." | 2.71 | [Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis]. ( Postavnyĭ, VE, 2005) |
"Helicobacter pylori gastritis is usually a lifelong disease which can cause different topographical inflammatory reactions and induce divergent effects on acid secretion in humans." | 2.70 | Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. ( Färkkilä, M; Koskenpato, J; Sipponen, P, 2002) |
" We performed serial endoscopy, checked for adverse events, and laboratory values." | 2.70 | Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies. ( Bardhan, KD; Bishop, AE; Cherian, P; Fischer, R; Lühmann, R; McCaldin, B; Morris, P; Ng, W; Perry, MJ; Polak, JM; Romanska, H; Rowland, A; Schneider, A; Thompson, M, 2001) |
" Sixty-eight patients received 30 mg of lansoprazole once daily, 500 mg of amoxicillin and 250 mg of metronidazole thrice daily for 2 weeks (LAM group), while the other 67 patients received the same dosage of those agents plus 18,000 tyrosine units of pronase thrice daily for 2 weeks (LAMP group)." | 2.70 | Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. ( Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A, 2002) |
"Omeprazole pretreatment did not influence eradication rates." | 2.69 | Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study. ( Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD; Victor, L, 1998) |
"The 1-week triple therapy was safe and effective for eradicating H." | 2.69 | Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. ( Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T, 1998) |
"pylori-related gastritis, have focused mainly on medium and long-term change following eradication therapies." | 2.69 | Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy. ( Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR, 1999) |
"Chronic urticaria is one of the most frequent skin diseases." | 2.69 | Helicobacter pylori as a possible bacterial focus of chronic urticaria. ( Brehler, R; Domschke, W; Foerster, E; Luger, TA; Pohle, T; Wustlich, S, 1999) |
" The aim of this study was to determine the optimal dose and duration of lansoprazole (LA) administration in combination with amoxicillin (AMPC) and metronidazole (MNZ)." | 2.69 | Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy. ( Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J, 1999) |
"Metronidazole resistance was found in 44% of pre-treatment cultures of H." | 2.69 | Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. ( Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI, 2000) |
"We present data on development of GERD from a controlled study of H." | 2.69 | Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. ( Befrits, R; Lindberg, G; Odman, B; Sjöstedt, S; Sörngård, H, 2000) |
"pylori-positive GERD patients randomly assigned to either an eradication or omeprazole-alone regime." | 2.69 | Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. ( Axon, AT; Bardhan, K; Dixon, MF; Moayyedi, P; Peacock, R; Walan, A; Wason, C, 2000) |
" HP was eradicated by combined treatment with high-dose omeprazole (2 x 40 mg) and amoxicillin (2 x 1,000 mg; n = 27) administered for 10 days (OME + AMX); alternatively, patients were treated with omeprazole monotherapy (OME) using the same dosage (n = 25)." | 2.68 | Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. ( Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Ruckdeschel, G; Sommer, A; Weingart, J, 1995) |
"Treatment with omeprazole plus amoxicillin or clarithromycin resulted in encouraging Helicobacter pylori cure rates in pilot and controlled studies." | 2.68 | High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. ( Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M, 1995) |
"Omeprazole has a strong inhibitory effect on H." | 2.68 | Effect of omeprazole on Helicobacter pylori urease activity in vivo. ( Domínguez-Muñoz, JE; Kalhori, N; Malfertheiner, P; Sauerbruch, T; Stoschus, B, 1996) |
"In five of 20 patients, MALT lymphomas were finally diagnosed." | 2.68 | Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? ( Bayerdörffer, E; Hatz, R; Lehn, N; Müller, S; Neubauer, A; Neubauer, B; Otto, P; Ritter, M; Rudolph, B; Seifert, E; Stolte, M; Thiede, C, 1997) |
" Thus, a true dose-response relationship exists between omeprazole and treatment success." | 2.68 | Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. ( Beker, JA; Dekker, CP; Farley, A; Jönsson, A; Klör, HU; Labenz, J, 1997) |
" Group II (n = 47) treated with the same drug and dosage for 2 weeks." | 2.68 | [Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. ( Bei, L; Chen, S; Chen, Z, 1996) |
" Physiologic factors that may contribute to a poor response to these drugs include the considerable variation in the bioavailability of PPIs, the need to take PPIs with meals, the influence of Helicobacter pylori-associated gastritis, and genetic variation in enzyme capacity, resulting in rapid and slow metabolizers of PPIs." | 2.42 | Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. ( Richter, JE, 2003) |
" Conversely, several studies have shown that long-term use of proton pump inhibitors is associated with progression and worsening of body gastritis exclusively in Helicobacter pylori-positives." | 2.40 | Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors? ( Rauws, EA, 1997) |
"argyrophilic gastric carcinoids." | 2.38 | Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. ( Rindi, G; Silini, E; Solcia, E; Villani, L, 1993) |
"Gastritis is a common inflammation of stomach with multiple pathogenesis." | 1.72 | Octreotide-based therapies effectively protect mice from acute and chronic gastritis. ( Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q, 2022) |
" Examination of eradication rates according to CAM dosage revealed an eradication rate of 65." | 1.40 | Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). ( Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A, 2014) |
"In two patients with MALT lymphoma, H." | 1.33 | Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients. ( Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K, 2005) |
"Chronic gastritis was evaluated according to sydney system." | 1.33 | [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori]. ( Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A, 2006) |
"Omeprazole, 20 mg b." | 1.32 | Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. ( el-Zimaity, HM; Graham, DY; Opekun, AR; Osato, MS; Yamaoka, Y, 2003) |
"Gastric metaplasia was endoscopically and histologically evaluated before and after eradication of this bacterium." | 1.32 | Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. ( Sano, T; Urakami, Y, 2003) |
"We report on two patients with schizoaffective disorder who received omeprazole in addition to clozapine because of gastrointestinal complaints." | 1.32 | Omeprazole reduces clozapine plasma concentrations. A case report. ( Bergemann, N; Frick, A; Kopitz, J, 2003) |
"Omeprazole was more effective than famotidine in keeping gastric pH high and lowering the total gastric acid output." | 1.32 | Omeprazole is more effective than famotidine for preventing acute gastritis in rats. ( Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S, 2004) |
" pylori-infected mucosa and that inhibited the loss of CAM bioavailability in the acidic environment." | 1.32 | Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. ( Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K, 2004) |
"Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors." | 1.31 | Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002) |
"pylori and oesophagitis is mediated by the effect of H." | 1.31 | Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease? ( Bianchi Porro, G; Pace, F, 2000) |
"Treatment with omeprazole, amoxicillin, and clarithromycin resulted in eradication of the infection in all and in resolution of the clinical symptoms in 15 (80%) of 19 patients who had a follow-up examination." | 1.31 | Helicobacter pylori infection in recurrent abdominal pain. ( Braegger, CP; Frank, F; Stallmach, T; Stricker, T, 2000) |
"Lymphocytic gastritis is characterized by intense lymphocytic infiltration of gastric epithelium." | 1.31 | [Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole]. ( Bellanger, J; Cacoub, P; Costedoat-Chalumeau, N; Godeau, P; Piette, JC; Sbaï, A, 2000) |
"When omeprazole-treated mice were treated with antibiotics alone, elevated plasma gastrin levels returned to baseline and D cell numbers returned to resting levels despite persistent hypochlorhydria." | 1.31 | Hypergastrinemia in response to gastric inflammation suppresses somatostatin. ( Ferguson, A; Merchant, JL; Rieder, G; Samuelson, LC; Zavros, Y, 2002) |
"Chronic gastritis was diagnosed in 63 (77." | 1.31 | Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. ( Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S, 2001) |
"Lactoferrin (Lf) is an iron-binding glycoprotein present in milk, lacrimae, saliva, and gastroduodenal secretions." | 1.30 | Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. ( Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N, 1997) |
"More than 90% of gastric MALT lymphomas are diagnosed in patients with chronic, Helicobacter pylori-associated gastritis." | 1.30 | Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. ( Alpen, B; Bayerdörffer, E; Ehninger, G; Morgner, A; Neubauer, A; Neubauer, B; Ritter, M; Stolte, M; Thiede, C; Wündisch, T, 1997) |
"Lansoprazole was mostly prescribed in patients with reflux oesophagitis (55." | 1.30 | A prospective follow-up study of 5669 users of lansoprazole in daily practice. ( Claessens, A; Heerdink, E; Lamers, CB; Leufkens, H; van Eijk, J, 1997) |
"Gastritis was scored according to Sydney criteria." | 1.30 | Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. ( Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L, 1998) |
"The laryngitis was clinically and endoscopically unchanged in ten of the twelve (83." | 1.30 | [Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study]. ( Arps, H; Diehl, KL; Draf, W; Jaspersen, D; Kind, M; Weber, R, 1998) |
"Pretreatment with omeprazole (30 mg/kg s." | 1.30 | Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress. ( Arakawa, T; Higuchi, K; Kobayashi, K; Kuroki, T; Takaishi, O; Yamasaki, K, 1999) |
"H." | 1.29 | Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy. ( Avunduk, C; Coughlin, B; Hampf, F; Navab, F, 1995) |
"It is used for treatment of gastroduodenal ulcers, reflux oesophagitis and Zollinger Ellison's syndrome." | 1.29 | [The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis]. ( Drábek, J; Hanika, J; Soucková, A; Vejvalka, J; Zelenková, J; Zeman, V, 1993) |
"Treatment with omeprazole, a proton pump inhibitor, for 2 months, followed by famotidine, resulted in clinical improvement with resolution of the gastroduodenal lesions and protein loss." | 1.29 | Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. ( Kuroda, T; Miura, T; Murata, I; Otsuki, M; Tabaru, A; Yoshikawa, I, 1996) |
"Omeprazole treatment produces lower intragastric pH values 4 weeks after cure of Helicobacter pylori infection than before." | 1.29 | Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. ( Armstrong, D; Blum, AL; Börsch, G; Idström, JP; Labenz, J; Stolte, M; Verdú, EF, 1996) |
"Treatment with omeprazole also failed to bring about healing of the ulceration which, at times, measured up to 10 cm in diameter." | 1.28 | Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration. ( Gail, K; Mihaljevic, L; Stolte, M, 1991) |
"The omeprazole plasma levels were 611 +/- 323 and 881 +/- 533 ng/ml after 2 and 4 h." | 1.28 | Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine. ( Bode, JC; Klotz, U; Sarem-Aslani, A; Treiber, G; Walker, S, 1991) |
"2." | 1.28 | [Current perspectives in ulcer disease]. ( Beglinger, C, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (1.03) | 18.7374 |
1990's | 190 (48.97) | 18.2507 |
2000's | 161 (41.49) | 29.6817 |
2010's | 28 (7.22) | 24.3611 |
2020's | 5 (1.29) | 2.80 |
Authors | Studies |
---|---|
Lin, X | 1 |
Chen, H | 1 |
Lin, YN | 1 |
Xu, WF | 1 |
Wang, Y | 1 |
Huang, H | 1 |
Wu, JW | 1 |
Che, Y | 1 |
Ding, CJ | 1 |
Zhang, Q | 1 |
Cao, WL | 1 |
Cao, LJ | 1 |
Kim, SE | 1 |
Memon, A | 1 |
Kim, BY | 1 |
Jeon, H | 1 |
Lee, WK | 1 |
Kang, SC | 1 |
Yu, L | 1 |
Li, R | 1 |
Liu, W | 2 |
Zhou, Y | 1 |
Li, Y | 1 |
Qin, Y | 1 |
Chen, Y | 1 |
Xu, Y | 1 |
Santos Santamarta, F | 1 |
Bonoso Criado, R | 1 |
Pérez-Millán, AG | 1 |
Tan, B | 1 |
Luo, HQ | 1 |
Xu, H | 1 |
Lv, NH | 1 |
Shi, RH | 1 |
Luo, HS | 1 |
Li, JS | 1 |
Ren, JL | 1 |
Zou, YY | 1 |
Li, YQ | 1 |
Ji, F | 1 |
Fang, JY | 1 |
Qian, JM | 1 |
Qin, S | 1 |
Huang, K | 1 |
Fang, Z | 1 |
Yin, J | 1 |
Dai, R | 1 |
Agudo-Fernández, S | 1 |
González Blanco, A | 1 |
Salar, A | 1 |
Köksal, AS | 1 |
Onder, FO | 1 |
Torun, S | 1 |
Parlak, E | 1 |
Sayilir, A | 1 |
Tayfur, O | 1 |
Yildiz, H | 1 |
Ozbalci, GS | 1 |
Kayaçetin, E | 1 |
Sarkeshikian, SS | 1 |
Iranikhah, A | 1 |
Ghadir, MR | 1 |
Baracho, NC | 1 |
Ribeiro, RV | 1 |
Pereira, RM | 1 |
Irulegui, Rde S | 1 |
Lambert, D | 1 |
Rouger, C | 1 |
Diebold, MD | 1 |
Ramaholimihaso, F | 1 |
Boulagnon, C | 1 |
Nguyen, Y | 1 |
Hentzien, M | 1 |
Jaussaud, R | 1 |
Bani-Sadr, F | 1 |
Poirier-Guay, MP | 1 |
Bélanger, MC | 1 |
Frank, D | 1 |
Kawai, T | 1 |
Takahashi, S | 2 |
Suzuki, H | 4 |
Sasaki, H | 1 |
Nagahara, A | 1 |
Asaoka, D | 1 |
Matsuhisa, T | 1 |
Masaoaka, T | 1 |
Nishizawa, T | 1 |
Suzuki, M | 3 |
Ito, M | 2 |
Kurihara, N | 1 |
Omata, F | 1 |
Mizuno, S | 1 |
Torii, A | 1 |
Kawakami, K | 1 |
Ohkusa, T | 1 |
Tokunaga, K | 1 |
Mine, T | 1 |
Sakaki, N | 1 |
Batgi, H | 1 |
Akbal, E | 1 |
Koçak, E | 1 |
Akyürek, Ö | 1 |
Köklü, S | 1 |
Dönmez, M | 1 |
Güneş, F | 1 |
Wang, FY | 1 |
Liu, JM | 1 |
Luo, HH | 1 |
Liu, AH | 1 |
Jiang, Y | 2 |
John, A | 1 |
Al Kaabi, S | 1 |
Doiphode, S | 1 |
Chandra, P | 1 |
Sharma, M | 2 |
Babu, R | 1 |
Yacoub, R | 1 |
Derbala, M | 1 |
Kato, K | 2 |
Tominaga, K | 1 |
Sugimori, S | 1 |
Nagami, Y | 1 |
Kamata, N | 1 |
Yamagami, H | 1 |
Tanigawa, T | 1 |
Shiba, M | 1 |
Watanabe, T | 1 |
Fujiwara, Y | 1 |
Arakawa, T | 2 |
Wang, L | 1 |
Lin, Z | 1 |
Chen, S | 2 |
Li, J | 1 |
Chen, C | 1 |
Huang, Z | 1 |
Ye, B | 1 |
Ding, J | 1 |
Li, W | 2 |
Wu, L | 1 |
Meng, L | 1 |
Du, Q | 1 |
Si, J | 1 |
Körber, A | 1 |
Dissemond, J | 1 |
De Leest, HT | 1 |
Steen, KS | 1 |
Bloemena, E | 2 |
Lems, WF | 1 |
Kuipers, EJ | 3 |
Van de Laar, MA | 1 |
Bijlsma, JW | 1 |
Janssen, M | 1 |
Houben, HH | 1 |
Kostense, PJ | 1 |
Boers, M | 1 |
Dijkmans, BA | 1 |
Bago, J | 1 |
Pevec, B | 1 |
Tomić, M | 1 |
Marusić, M | 2 |
Bakula, V | 1 |
Bago, P | 1 |
Petronilho, F | 1 |
Araújo, JH | 2 |
Steckert, AV | 1 |
Rezin, GT | 2 |
Ferreira, GK | 1 |
Roesler, R | 2 |
Schwartsmann, G | 2 |
Dal-Pizzol, F | 2 |
Streck, EL | 2 |
Esedov, EM | 1 |
Magomedéminova, AS | 1 |
Koosirirat, C | 1 |
Linpisarn, S | 1 |
Changsom, D | 1 |
Chawansuntati, K | 1 |
Wipasa, J | 1 |
van Zanten, SV | 1 |
Desai, S | 1 |
Best, L | 1 |
Cooper-Lesins, G | 1 |
Malatjalian, D | 2 |
Haldane, D | 1 |
Peltekian, K | 1 |
Kohler, JE | 1 |
Blass, AL | 1 |
Liu, J | 1 |
Tai, K | 1 |
Soybel, DI | 1 |
Sood, S | 1 |
Muthuraman, A | 1 |
Gill, NS | 1 |
Bali, M | 1 |
Sharma, PD | 1 |
Zhang, J | 1 |
Ye, LP | 1 |
Shen, LY | 1 |
Petronilho, FC | 1 |
Gonçalves, CL | 1 |
Daufenbach, JF | 1 |
Cardoso, MR | 1 |
Yang, JC | 1 |
Wang, HL | 1 |
Chern, HD | 1 |
Shun, CT | 1 |
Lin, BR | 1 |
Lin, CJ | 1 |
Wang, TH | 1 |
Buonavolontà, R | 1 |
Miele, E | 1 |
Russo, D | 1 |
Vecchione, R | 1 |
Staiano, A | 1 |
Kim, JY | 1 |
Kim, N | 1 |
Park, HK | 1 |
Jo, HJ | 1 |
Shin, CM | 1 |
Lee, SH | 1 |
Park, YS | 1 |
Hwang, JH | 1 |
Kim, JW | 1 |
Jeong, SH | 1 |
Lee, DH | 1 |
Nam, RH | 1 |
Kim, JM | 2 |
Lee, JH | 1 |
Jung, HC | 1 |
Song, IS | 1 |
Tian, XL | 1 |
Zhang, JZ | 1 |
Zhou, LY | 1 |
Geng, QM | 1 |
Han, YJ | 1 |
Seyyedmajidi, M | 1 |
Falaknazi, K | 1 |
Mirsattari, D | 1 |
Zojaji, H | 1 |
Roshani, M | 1 |
Lahmi, F | 1 |
Orimi, PG | 1 |
Hadizadeh, M | 1 |
Zali, M | 1 |
Figura, N | 2 |
Moretti, E | 1 |
Vaglio, L | 1 |
Langone, F | 1 |
Vernillo, R | 1 |
Vindigni, C | 1 |
Giordano, N | 1 |
Kloesel, B | 1 |
Chandan, VS | 1 |
Alexander, GL | 1 |
Prasad, R | 1 |
De Silva, M | 1 |
Koskenpato, J | 1 |
Färkkilä, M | 2 |
Sipponen, P | 2 |
Mak, SK | 2 |
Loo, CK | 2 |
Wong, AM | 1 |
Wong, PN | 2 |
Lo, KY | 2 |
Tong, GM | 2 |
Lam, EK | 2 |
Wong, AK | 2 |
Murakami, K | 5 |
Sato, R | 4 |
Okimoto, T | 4 |
Nasu, M | 4 |
Fujioka, T | 5 |
Kodama, M | 4 |
Kagawa, J | 1 |
Sato, S | 2 |
Abe, H | 1 |
Arita, T | 2 |
Hirayama, F | 1 |
Takagi, S | 1 |
Yokoyama, Y | 1 |
Yamamoto, K | 1 |
Iwao, E | 1 |
Haga, K | 1 |
Cui, M | 1 |
Hu, F | 1 |
Jiang, H | 1 |
Zheng, X | 2 |
Kawano, S | 1 |
Wepner, U | 1 |
Graham, DY | 2 |
Opekun, AR | 1 |
Yamaoka, Y | 1 |
Osato, MS | 1 |
el-Zimaity, HM | 2 |
Miki, I | 1 |
Aoyama, N | 3 |
Sakai, T | 1 |
Shirasaka, D | 2 |
Wambura, CM | 1 |
Maekawa, S | 2 |
Kuroda, K | 2 |
Tamura, T | 2 |
Kita, T | 2 |
Sakaeda, T | 1 |
Okumura, K | 2 |
Kasuga, M | 3 |
Orr, CF | 1 |
Rowe, DB | 1 |
Urakami, Y | 1 |
Sano, T | 1 |
Ozgenc, F | 1 |
Akman, SA | 1 |
Arikan, C | 1 |
Alkanat, MB | 1 |
Aydogdu, S | 1 |
Yagci, RV | 1 |
Muela Molinero, A | 1 |
Ballesteros del Río, B | 1 |
Nistal de Paz, F | 1 |
Fernandez Pérez, E | 1 |
Aguas, M | 1 |
Pons, M | 1 |
Barrera, N | 1 |
Arboix, A | 1 |
Eguileor, B | 1 |
Delás, J | 1 |
Moazzez, R | 1 |
Bartlett, D | 1 |
Anggiansah, A | 1 |
Kaise, M | 1 |
Miwa, J | 1 |
Iihara, K | 1 |
Suzuki, N | 1 |
Oda, Y | 1 |
Ohta, Y | 1 |
Miyamoto, M | 2 |
Haruma, K | 5 |
Yoshihara, M | 3 |
Sumioka, M | 2 |
Kamada, T | 2 |
Masuda, H | 1 |
Nishisaka, T | 2 |
Tanaka, S | 2 |
Chayama, K | 2 |
Hiyama, T | 1 |
Frick, A | 1 |
Kopitz, J | 1 |
Bergemann, N | 1 |
Sapone, A | 1 |
Vaira, D | 2 |
Trespidi, S | 1 |
Perna, F | 1 |
Gatta, L | 2 |
Tampieri, A | 1 |
Ricci, C | 2 |
Cantelli-Forti, G | 1 |
Miglioli, M | 3 |
Biagi, GL | 1 |
Paolini, M | 1 |
Hage, E | 1 |
Hendel, L | 1 |
Gustafsen, J | 1 |
Hendel, J | 1 |
van Zanten, SJ | 1 |
Kolesnikow, T | 1 |
Leung, V | 1 |
O'Rourke, JL | 1 |
Lee, A | 1 |
Santarelli, L | 1 |
Gabrielli, M | 1 |
Candelli, M | 1 |
Cremonini, F | 1 |
Nista, EC | 1 |
Cammarota, G | 1 |
Gasbarrini, G | 3 |
Gasbarrini, A | 2 |
Richter, JE | 1 |
Uthaisaengsook, W | 1 |
Nelis, GF | 1 |
Klinkenberg-Knol, EC | 3 |
Snel, P | 2 |
Goldfain, D | 1 |
Kolkman, JJ | 1 |
Festen, HP | 1 |
Dent, J | 2 |
Zeitoun, P | 1 |
Havu, N | 2 |
Lamm, M | 1 |
Walan, A | 3 |
Ley, C | 1 |
Mohar, A | 1 |
Guarner, J | 1 |
Herrera-Goepfert, R | 1 |
Figueroa, LS | 1 |
Halperin, D | 1 |
Johnstone, I | 1 |
Parsonnet, J | 1 |
Furuta, T | 3 |
Shirai, N | 2 |
Xiao, F | 1 |
El-Omar, EM | 1 |
Rabkin, CS | 1 |
Sugimura, H | 1 |
Ishizaki, T | 2 |
Ohashi, K | 2 |
Gillen, D | 2 |
Wirz, AA | 1 |
McColl, KE | 2 |
Di Mario, F | 5 |
Ingegnoli, A | 1 |
Dal Bò, N | 2 |
Cavestro, GM | 1 |
Moussa, AM | 1 |
Cavallaro, LG | 1 |
Aragona, G | 1 |
Iori, V | 1 |
Pilotto, A | 5 |
Franzè, A | 1 |
Rugge, M | 3 |
Lane, E | 1 |
Lobetti, R | 1 |
Burroughs, R | 1 |
Asaumi, N | 1 |
Niiya, K | 1 |
Yoshida, C | 1 |
Shibakura, M | 1 |
Niiya, M | 1 |
Tanimoto, M | 1 |
Anagnostopoulos, GK | 1 |
Tsiakos, S | 1 |
Margantinis, G | 1 |
Kostopoulos, P | 1 |
Arvanitidis, D | 1 |
Tiesmeier, J | 1 |
Hinner, H | 1 |
Kraus, J | 1 |
Schuppert, F | 1 |
Oderda, G | 1 |
Marinello, D | 1 |
Lerro, P | 2 |
Kuvidi, M | 1 |
de'Angelis, GL | 1 |
Ferzetti, A | 1 |
Cucchiara, S | 1 |
Franco, MT | 1 |
Romano, C | 1 |
Strisciuglio, P | 1 |
Pensabene, L | 1 |
Topaloglu, U | 1 |
Muftuoglu, T | 1 |
Akturk, Z | 1 |
Ekinci, H | 1 |
Peker, O | 1 |
Unalmiser, S | 1 |
Masaoka, T | 1 |
SuzukiKurabayashi, HK | 1 |
Kamiya, AG | 1 |
Ishii, H | 3 |
Kondo, Y | 2 |
Joh, T | 2 |
Sasaki, M | 2 |
Oshima, T | 3 |
Itoh, K | 2 |
Tanida, S | 2 |
Kataoka, H | 2 |
Ohara, H | 2 |
Nomura, T | 1 |
Itoh, M | 2 |
Leung, WK | 1 |
Lin, SR | 1 |
Ching, JY | 1 |
To, KF | 1 |
Ng, EK | 1 |
Chan, FK | 1 |
Lau, JY | 1 |
Sung, JJ | 1 |
Ozturk, Y | 1 |
Buyukgebiz, B | 1 |
Ozer, E | 1 |
Arslan, N | 1 |
Bekem, O | 1 |
Hizli, S | 1 |
Wambura, C | 1 |
Ebara, S | 1 |
Watanabe, Y | 1 |
Calvet, X | 1 |
Montserrat, A | 1 |
Güell, M | 1 |
Vergara, M | 1 |
Gené, E | 1 |
Rollot, F | 1 |
Pajot, O | 1 |
Chauvelot-Moachon, L | 1 |
Nazal, EM | 1 |
Kélaïdi, C | 1 |
Blanche, P | 1 |
Farinati, F | 1 |
Cardin, R | 1 |
Russo, VM | 1 |
Busatto, G | 1 |
Franco, M | 1 |
Falda, A | 1 |
Mescoli, C | 1 |
Watanabe, K | 3 |
Kashimura, K | 1 |
Miura, M | 1 |
Ootsu, S | 1 |
Miyajima, H | 1 |
Arkkila, PE | 1 |
Seppälä, K | 2 |
Kosunen, TU | 2 |
Mäkinen, J | 1 |
Rautelin, H | 2 |
Bardhan, KD | 5 |
Bishop, AE | 2 |
Polak, JM | 2 |
Romanska, HM | 1 |
Rowland, A | 2 |
Thompson, M | 2 |
Morris, P | 2 |
Schaefer-Preuss, S | 1 |
Luehmann, R | 1 |
McCaldin, B | 2 |
Mana, F | 1 |
Van Laer, W | 1 |
Van Laere, W | 1 |
Bossuyt, A | 1 |
Urbain, D | 1 |
Hata, M | 1 |
Shiono, M | 1 |
Sekino, H | 1 |
Furukawa, H | 1 |
Sezai, A | 1 |
Iida, M | 1 |
Yoshitake, I | 1 |
Hattori, T | 1 |
Wakui, S | 1 |
Soeda, M | 1 |
Taoka, M | 1 |
Negishi, N | 1 |
Sezai, Y | 1 |
Chang, CC | 1 |
Chen, SH | 1 |
Lien, GS | 1 |
Lee, YJ | 2 |
Lou, HY | 1 |
Hsieh, CR | 1 |
Fang, CL | 1 |
Pan, S | 1 |
Babic, Z | 1 |
Nesanovic, M | 1 |
Lucijanic-Mlinac, M | 1 |
Stajcar, V | 1 |
Rindi, G | 2 |
Fiocca, R | 5 |
Morocutti, A | 1 |
Jacobs, A | 1 |
Miller, N | 1 |
Thjodleifsson, B | 1 |
Park, SH | 1 |
Park, DI | 1 |
Kim, SH | 1 |
Kim, HJ | 2 |
Cho, YK | 1 |
Sung, IK | 1 |
Sohn, CI | 1 |
Jeon, WK | 1 |
Kim, BI | 1 |
Keum, DK | 1 |
Hershko, C | 1 |
Hoffbrand, AV | 1 |
Keret, D | 1 |
Souroujon, M | 1 |
Maschler, I | 1 |
Monselise, Y | 1 |
Lahad, A | 1 |
Sagehashi, Y | 1 |
Sugimoto, M | 1 |
Nakamura, A | 1 |
Kodaira, M | 1 |
Kenmotsu, K | 1 |
Nagano, M | 1 |
Egashira, T | 1 |
Ueda, K | 1 |
Yoneyama, M | 1 |
Hishida, A | 1 |
Min, YS | 2 |
Yim, SH | 2 |
Bai, KL | 2 |
Choi, HJ | 1 |
Jeong, JH | 1 |
Song, HJ | 2 |
Park, SY | 1 |
Ham, I | 2 |
Whang, WK | 2 |
Sohn, UD | 2 |
Okiyama, Y | 1 |
Matsuzawa, K | 1 |
Hidaka, E | 1 |
Sano, K | 1 |
Akamatsu, T | 2 |
Ota, H | 2 |
Choi, SM | 1 |
Kim, DH | 1 |
Oh, TY | 1 |
Ahn, BO | 1 |
Kwon, JW | 1 |
Kim, WB | 1 |
El-Matary, W | 1 |
Dalzell, M | 1 |
Ogasawara, N | 1 |
Okada, N | 1 |
Sano, H | 1 |
Nakao, H | 1 |
Sobue, S | 1 |
Kim, SS | 1 |
Meitner, P | 1 |
Konkin, TA | 1 |
Cho, YS | 1 |
Resnick, MB | 1 |
Moss, SF | 1 |
Magalhães, AF | 1 |
Carvalhaes, A | 1 |
Natan-Eisig, J | 1 |
Paraíso-Ferraz, JG | 1 |
Trevisan, M | 1 |
Zaterkaad, S | 1 |
Capitanini, A | 1 |
Lupi, A | 1 |
Osteri, F | 1 |
Petrone, I | 1 |
Del Corso, C | 1 |
Straniti, M | 1 |
Gallieni, M | 1 |
Rossi, A | 1 |
Francavilla, R | 1 |
Lionetti, E | 1 |
Castellaneta, SP | 1 |
Magistà, AM | 1 |
Boscarelli, G | 1 |
Piscitelli, D | 1 |
Amoruso, A | 1 |
Di Leo, A | 1 |
Miniello, VL | 1 |
Francavilla, A | 1 |
Cavallo, L | 1 |
Ierardi, E | 1 |
Mazzoleni, LE | 1 |
Sander, GB | 1 |
Ott, EA | 1 |
Barros, SG | 1 |
Francesconi, CF | 1 |
Polanczyk, CA | 1 |
Wortmann, AC | 1 |
Theil, AL | 1 |
Fritscher, LG | 1 |
Rivero, LF | 1 |
Cartell, A | 1 |
Edelweiss, MI | 1 |
Uchôa, DM | 1 |
Prolla, JC | 1 |
Chan, AO | 1 |
Peng, JZ | 1 |
Lam, SK | 2 |
Lai, KC | 1 |
Yuen, MF | 1 |
Cheung, HK | 1 |
Kwong, YL | 1 |
Rashid, A | 1 |
Chan, CK | 1 |
Wong, BC | 1 |
Confino-Cohen, R | 1 |
Goldberg, A | 1 |
Madisch, A | 2 |
Miehlke, S | 5 |
Neuber, F | 1 |
Morgner, A | 2 |
Kuhlisch, E | 1 |
Rappel, S | 1 |
Lehn, N | 5 |
Bayerdörffer, E | 10 |
Seitz, G | 1 |
Stolte, M | 24 |
Abe, T | 1 |
Onoda, N | 1 |
Katsuragi, K | 1 |
Sawada, T | 1 |
Maeda, K | 1 |
Mino, A | 1 |
Ohira, M | 1 |
Ishikawa, T | 1 |
Wakasa, K | 1 |
Hirakawa, K | 1 |
Postavnyĭ, VE | 1 |
Perri, F | 2 |
Leandro, G | 4 |
Franceschi, M | 6 |
Centanni, M | 1 |
Gargano, L | 1 |
Canettieri, G | 1 |
Viceconti, N | 1 |
Franchi, A | 1 |
Delle Fave, G | 3 |
Annibale, B | 4 |
Kim, JH | 1 |
Dietrich, JW | 1 |
Boehm, BO | 1 |
Kawakami, E | 1 |
Machado, RS | 1 |
Ogata, SK | 1 |
Langner, M | 1 |
Fukushima, E | 1 |
Carelli, AP | 1 |
Bonucci, VC | 1 |
Patricio, FR | 1 |
Khayat, O | 1 |
Kilani, A | 1 |
Chedly-Debbiche, A | 1 |
Zeddini, A | 1 |
Gargouri, D | 1 |
Kharrat, J | 1 |
Souissi, A | 1 |
Ghorbel, AJ | 1 |
Ben Ayed, M | 1 |
Ben Khelifa, H | 1 |
Cadranel, S | 1 |
Bontemps, P | 1 |
Van Biervliet, S | 1 |
Alliet, P | 1 |
Lauvau, D | 1 |
Vandenhoven, G | 1 |
Vandenplas, Y | 1 |
Minushkin, ON | 1 |
Volodin, DV | 1 |
Zverkov, IV | 1 |
Ivanova, OI | 1 |
Shuleshova, AG | 1 |
Burdina, EG | 1 |
Malinovskaia, NK | 1 |
Rapoport, SI | 1 |
Zhernakova, NI | 1 |
Rybnikova, SN | 1 |
Postnikova, LI | 1 |
Parkhomenko, IE | 1 |
Serebrova, SIu | 1 |
Czerwionka-Szaflarska, M | 1 |
Brazowski, J | 1 |
Koussoulas, V | 1 |
Vassiliou, S | 1 |
Spyridaki, E | 1 |
Demonakou, M | 1 |
Vaki, I | 1 |
Barbatzas, C | 1 |
Giamarellou, H | 1 |
Giamarellos-Bourboulis, EJ | 1 |
Miwa, H | 1 |
Tomita, T | 1 |
Kori, M | 1 |
Cohen, S | 1 |
Levine, A | 1 |
Givony, S | 1 |
Sokolovskaia-Ziv, N | 1 |
Melzer, E | 1 |
Granot, E | 1 |
Elseweidy, MM | 1 |
Younis, NN | 1 |
Amin, RS | 1 |
Abdallah, FR | 1 |
Fathy, AM | 1 |
Yousif, ZA | 1 |
Robles-Jara, C | 1 |
Robles-Medranda, C | 1 |
Moncayo, M | 1 |
Landivar, B | 1 |
Parrales, J | 1 |
Avunduk, C | 1 |
Navab, F | 1 |
Hampf, F | 1 |
Coughlin, B | 1 |
Labenz, J | 14 |
Peitz, U | 4 |
Tillenburg, B | 3 |
Köhl, H | 1 |
Becker, T | 2 |
Börsch, G | 8 |
Schepp, W | 1 |
Jhala, NC | 1 |
McFarland, MM | 1 |
Brightman, SA | 1 |
Morale, B | 1 |
Rubin, W | 1 |
Atkinson, BF | 1 |
Reinauer, S | 1 |
Megahed, M | 1 |
Goerz, G | 1 |
Ruzicka, T | 1 |
Borchard, F | 2 |
Susanto, F | 1 |
Reinauer, H | 1 |
Roberts, SJ | 1 |
Bateman, DN | 1 |
Blum, AL | 5 |
Kreiss, C | 1 |
Armstrong, D | 5 |
Cahill, RJ | 1 |
Xia, H | 1 |
Kilgallen, C | 1 |
Beattie, S | 1 |
Hamilton, H | 1 |
O'Morain, C | 5 |
Mannes, GA | 2 |
Sommer, A | 1 |
Höchter, W | 1 |
Weingart, J | 1 |
Hatz, R | 2 |
Ruckdeschel, G | 1 |
Dirschedl, P | 1 |
Blandizzi, C | 2 |
Gherardi, G | 2 |
Marveggio, C | 2 |
Natale, G | 2 |
Carignani, D | 1 |
Del Tacca, M | 1 |
Yabana, T | 1 |
Kobayashi, T | 1 |
Sugiyama, T | 4 |
Uyterlinde, AM | 1 |
Peña, AS | 1 |
Hazenberg, HJ | 1 |
Lindeman, J | 1 |
Meuwissen, SG | 1 |
Graham, KS | 1 |
Malaty, H | 1 |
Genta, RM | 1 |
Cole, RA | 1 |
al-Assi, MT | 1 |
Yousfi, MM | 1 |
Neil, GA | 1 |
Ozmen, MM | 1 |
Johnson, CD | 1 |
Choné, L | 1 |
Fléjou, JF | 1 |
Grignon, Y | 1 |
Bigard, MA | 1 |
Solcia, E | 7 |
Silini, E | 1 |
Villani, L | 5 |
Metz, DC | 1 |
Getz, HD | 1 |
Forné, M | 1 |
Viver, JM | 1 |
Espinós, JC | 1 |
Coll, I | 1 |
Tresserra, F | 1 |
Garau, J | 1 |
Park, KN | 1 |
Hahm, JS | 1 |
Neubauer, A | 5 |
Rudolph, B | 2 |
Thiede, C | 3 |
Eidt, S | 2 |
Gisbert, JP | 3 |
Boixeda, D | 4 |
Alvarez Baleriola, I | 3 |
Redondo, C | 2 |
De Rafael, L | 1 |
Martín de Argila, C | 3 |
Hernández Ranz, F | 1 |
Sood, A | 1 |
Jain, NP | 1 |
Chawla, LS | 1 |
Kumar, R | 1 |
Wagner, S | 2 |
Beil, W | 1 |
Mai, UE | 1 |
Bokemeyer, C | 1 |
Meyer, HJ | 1 |
Manns, MP | 1 |
Trespi, E | 3 |
Broglia, F | 1 |
Luinetti, O | 3 |
Karjoo, M | 1 |
Kane, R | 1 |
tho Pesch, S | 1 |
Müller, W | 1 |
Peters, U | 1 |
Adamek, RJ | 2 |
Szymanski, C | 1 |
Pfaffenbach, B | 1 |
Opferkuch, W | 2 |
Ricken, D | 1 |
Wegener, M | 2 |
Domian, C | 1 |
Bertrams, J | 1 |
Florent, C | 1 |
Domschke, W | 2 |
Goh, KL | 2 |
Peh, SC | 2 |
Parasakthi, N | 2 |
Wong, NW | 1 |
Tan, KK | 1 |
Lo, YL | 2 |
Polonio García, MJ | 1 |
Merino Romero, J | 1 |
Luque Ruano, A | 1 |
Sánchez Sánchez, JE | 1 |
Patterson, WK | 1 |
Sage, RE | 1 |
Keefe, DM | 1 |
Neri, M | 1 |
Susi, D | 1 |
Laterza, F | 1 |
Di Iorio, P | 1 |
Seccia, G | 1 |
Mezzetti, A | 1 |
Cuccurullo, F | 1 |
Krappweis, J | 1 |
Petereit, G | 1 |
Schentke, KU | 1 |
Kirch, W | 1 |
Axon, AT | 3 |
O'Connor, HJ | 1 |
Boldorini, R | 1 |
Perego, M | 2 |
Alvisi, C | 2 |
Lazzaroni, M | 2 |
Bianchi Porro, G | 4 |
Freston, JW | 1 |
Cellini, L | 4 |
Allocati, N | 3 |
Di Campli, E | 3 |
Dainelli, B | 2 |
Saltzman, JR | 1 |
Kowdley, KV | 1 |
Pedrosa, MC | 1 |
Sepe, T | 1 |
Golner, B | 1 |
Perrone, G | 1 |
Russell, RM | 1 |
Pallone, F | 1 |
Luzza, F | 1 |
Marcheggiano, A | 1 |
Biancone, L | 1 |
Torsoli, A | 1 |
Capurso, L | 1 |
Imoto, I | 2 |
Suzuki, S | 1 |
Zelenková, J | 1 |
Soucková, A | 1 |
Drábek, J | 1 |
Hanika, J | 1 |
Vejvalka, J | 1 |
Zeman, V | 1 |
Tucci, A | 2 |
Corinaldesi, R | 2 |
Stanghellini, V | 1 |
Paparo, GF | 2 |
Gasperoni, S | 1 |
Biasco, G | 2 |
Varoli, O | 1 |
Ricci-Maccarini, M | 1 |
Barbara, L | 2 |
Lamberts, R | 2 |
Creutzfeldt, W | 2 |
Strüber, HG | 1 |
Brunner, G | 2 |
Khulusi, S | 1 |
Badve, S | 1 |
Patel, P | 1 |
Lloyd, R | 1 |
Marrero, JM | 1 |
Finlayson, C | 1 |
Mendall, MA | 1 |
Northfield, TC | 1 |
Diehl, HG | 1 |
de Boer, WA | 1 |
Driessen, WM | 1 |
Grassi, SA | 1 |
Cassaro, M | 1 |
Donisi, PM | 1 |
Vianello, F | 1 |
Kusstatscher, S | 1 |
Salandin, S | 1 |
Grasso, GA | 1 |
Ferrana, M | 1 |
Battaglia, G | 1 |
Idström, JP | 4 |
Verdú, EF | 3 |
Dammann, HG | 2 |
Artan, R | 1 |
Gelen, T | 1 |
Bargiggia, S | 1 |
Maconi, G | 3 |
Cesana, B | 2 |
Carlsson, J | 1 |
Rudbäck, A | 1 |
Zeijlon, L | 1 |
Bazzoli, F | 1 |
Masulli, M | 1 |
Di Bartolomeo, S | 1 |
Stermer, E | 1 |
Levy, N | 1 |
Murata, I | 1 |
Yoshikawa, I | 1 |
Kuroda, T | 1 |
Tabaru, A | 1 |
Miura, T | 1 |
Otsuki, M | 1 |
Goenka, MK | 1 |
Das, K | 1 |
Vaiphei, K | 1 |
Nijhawan, R | 1 |
Kocbhar, R | 1 |
Gough, AL | 1 |
Long, RG | 1 |
Cooper, BT | 3 |
Fosters, CS | 1 |
Garrett, AD | 1 |
Langworthy, CH | 1 |
Nagahata, Y | 1 |
Kawakita, N | 1 |
Azumi, Y | 1 |
Numata, N | 1 |
Yano, M | 1 |
Saitoh, Y | 1 |
Stoschus, B | 1 |
Domínguez-Muñoz, JE | 1 |
Kalhori, N | 1 |
Sauerbruch, T | 1 |
Malfertheiner, P | 5 |
Bohmeyer, J | 1 |
Heller, A | 1 |
Hartig, C | 1 |
Wetenberger-Treumann, M | 1 |
Huchzermeyer, H | 1 |
Otte, HG | 1 |
Stadler, R | 1 |
Alder, JD | 1 |
Ewing, PJ | 1 |
Mitten, MJ | 1 |
Oleksijew, A | 1 |
Tanaka, SK | 1 |
Moreno, JA | 1 |
Pajares, JM | 2 |
Santander, C | 1 |
Carpintero, P | 1 |
Hermida, C | 1 |
Lara, S | 1 |
García Grávalos, R | 1 |
Nishizono, A | 1 |
Nagai, J | 1 |
Tokieda, M | 1 |
Kodama, R | 1 |
Kubota, T | 1 |
Rubin, CE | 1 |
Petersen, KU | 1 |
Malfertheimer, P | 1 |
Moshkowitz, M | 2 |
Konikoff, FM | 1 |
Peled, Y | 1 |
Brill, S | 2 |
Hallak, A | 1 |
Tiomny, E | 1 |
Santo, M | 1 |
Bujanover, Y | 2 |
Gilat, T | 1 |
Soffiati, G | 2 |
Scagnelli, M | 2 |
Bozzola, L | 3 |
Valerio, G | 3 |
Lux, G | 1 |
Jiménez, I | 1 |
Pérez García, JI | 1 |
Bock, H | 1 |
Mares, A | 1 |
Wang, XM | 1 |
Taniguchi, Y | 1 |
Nishifuku, K | 1 |
Kidaira, K | 1 |
Sato, K | 1 |
Sohara, H | 1 |
Kawada, H | 1 |
Kimura, K | 1 |
Kajiwara, M | 1 |
Caselli, M | 1 |
Trevisani, L | 1 |
Tursi, A | 1 |
Sartori, S | 1 |
Ruina, M | 1 |
Luzzi, I | 1 |
Gaudenzi, P | 1 |
Alvisi, V | 1 |
Dohil, R | 1 |
Israel, DM | 1 |
Hassall, E | 1 |
Eissele, R | 2 |
Simon, B | 1 |
Arnold, R | 2 |
Ritter, M | 2 |
Müller, S | 1 |
Neubauer, B | 2 |
Seifert, E | 2 |
Otto, P | 1 |
Delpre, G | 1 |
Livni, E | 1 |
Niv, Y | 1 |
Hele, C | 1 |
Nakao, K | 1 |
Ikemura, N | 1 |
Shibata, T | 1 |
Takaji, S | 1 |
Taguchi, Y | 1 |
Misaki, M | 1 |
Yamauchi, K | 1 |
Yamazaki, N | 1 |
Mur, M | 1 |
Ceña, G | 1 |
Abraira, V | 1 |
García Plaza, A | 2 |
Marignani, M | 1 |
Angeletti, S | 1 |
Bordi, C | 2 |
Malagnino, F | 1 |
Mancino, C | 1 |
Kato, S | 2 |
Takeyama, J | 1 |
Ebina, K | 1 |
Naganuma, H | 1 |
Götz, JM | 1 |
Thio, JL | 1 |
Verspaget, HW | 1 |
Offerhaus, GJ | 1 |
Biemond, I | 1 |
Lamers, CB | 2 |
Veenendaal, RA | 1 |
Vcev, A | 1 |
Vuković, D | 1 |
Ivandić, A | 1 |
Vceva, A | 1 |
Dmitrović, B | 1 |
Kovacić, D | 1 |
Volaric, M | 1 |
Paulini, D | 1 |
Mićunović, N | 1 |
Horvat, D | 1 |
Mihaljević, S | 1 |
Kim, MJ | 1 |
Michener, R | 1 |
Triadafilopoulos, G | 1 |
Beker, JA | 1 |
Dekker, CP | 1 |
Farley, A | 1 |
Klör, HU | 2 |
Jönsson, A | 1 |
Hirakawa, T | 1 |
Tan, WC | 1 |
Hogan, J | 1 |
Purkayastha, SK | 1 |
Lombard, M | 1 |
Krasner, N | 1 |
Uemura, N | 2 |
Oomoto, Y | 1 |
Mukai, T | 1 |
Okamoto, S | 2 |
Yamaguchi, S | 2 |
Mashiba, H | 2 |
Taniyama, K | 2 |
Sasaki, N | 2 |
Sumii, K | 2 |
Kajiyama, G | 2 |
Alpen, B | 2 |
Wündisch, T | 2 |
Ehninger, G | 2 |
Krishnamurthy, S | 1 |
Dayal, Y | 1 |
Leufkens, H | 1 |
Claessens, A | 1 |
Heerdink, E | 1 |
van Eijk, J | 1 |
Harford, W | 1 |
Lanza, F | 1 |
Arora, A | 1 |
Graham, D | 1 |
Haber, M | 1 |
Weissfeld, A | 1 |
Rose, P | 1 |
Siepman, N | 1 |
Mégraud, F | 1 |
Dettmer, A | 1 |
Rambow, A | 1 |
von Fritsch, E | 1 |
Fraser, AG | 1 |
Lind, T | 1 |
Veldhuyzen van Zanten, S | 2 |
Unge, P | 2 |
Spiller, R | 1 |
Bradette, M | 1 |
Chiba, N | 1 |
Wrangstadh, M | 1 |
Cederberg, C | 2 |
van der Hulst, RW | 1 |
Keller, JJ | 1 |
Rauws, EA | 2 |
Tytgat, GN | 1 |
Srinivasan, R | 1 |
Minocha, A | 1 |
Hunt, RH | 1 |
Cockeram, A | 1 |
Schep, G | 1 |
Sidorov, J | 1 |
Matisko, A | 1 |
Jewell, D | 1 |
Bouaniche, M | 1 |
Chassagne, P | 1 |
Landrin, I | 1 |
Fartoukh, C | 1 |
Doucet, J | 1 |
Metayer, J | 1 |
Bercoff, E | 1 |
Misiewicz, JJ | 1 |
Harris, AW | 1 |
Levi, S | 1 |
Kerr, GD | 1 |
Dixon, MF | 2 |
Langworthy, H | 1 |
Piper, D | 1 |
Berstad, AE | 1 |
Hatlebakk, JG | 1 |
Maartmann-Moe, H | 1 |
Berstad, A | 1 |
Brandtzaeg, P | 1 |
Marzio, L | 2 |
Angelucci, D | 1 |
Grossi, L | 2 |
Diodoro, MG | 1 |
Dubois, A | 1 |
Berg, DE | 1 |
Fiala, N | 1 |
Heman-Ackah, LM | 1 |
Perez-Perez, GI | 1 |
Blaser, MJ | 1 |
Paramsothy, M | 1 |
Azian, M | 1 |
Bux, S | 1 |
Ong, KK | 1 |
Pilato, FP | 1 |
Damilano, I | 1 |
Berquist, WE | 1 |
Lanas Arbeloa, A | 1 |
Serrano Aulló, MT | 1 |
Carnicer, J | 1 |
Meining, A | 3 |
Schmitz, JM | 1 |
Alexandridis, T | 1 |
Malizia, T | 2 |
Tejada, M | 1 |
Marchetti, F | 1 |
Favini, P | 1 |
Pizzarelli, G | 1 |
Campa, M | 2 |
Senesi, S | 2 |
Chen, Z | 1 |
Bei, L | 1 |
Baba, S | 1 |
Takashima, M | 1 |
Futami, H | 1 |
Arai, H | 1 |
Kajimura, M | 1 |
Hanai, H | 1 |
Kaneko, E | 1 |
Kader, SA | 1 |
Mansour, AM | 1 |
Mohran, Z | 1 |
el-Taoil, A | 1 |
Abdalla, KF | 1 |
Poli, L | 1 |
Bocus, P | 1 |
Togliani, T | 1 |
Mazzoni, C | 1 |
Orcioni, GF | 1 |
Agosti, R | 1 |
Grigioni, WF | 1 |
Sottili, S | 1 |
Caletti, G | 1 |
Mori, M | 1 |
Sakaguchi, AA | 1 |
Miura, S | 1 |
Parente, F | 1 |
Imbesi, V | 1 |
Cucino, C | 1 |
Manzionna, G | 1 |
Vago, L | 1 |
Reif, S | 1 |
Ringel, Y | 1 |
Arber, N | 1 |
Halpern, Z | 1 |
Jaspersen, D | 1 |
Weber, R | 1 |
Diehl, KL | 1 |
Kind, M | 1 |
Arps, H | 1 |
Draf, W | 1 |
Verdú, E | 2 |
Bercík, P | 2 |
Costa, F | 1 |
Marchi, S | 1 |
Bellini, M | 1 |
Maltinti, G | 1 |
Tacca, MD | 1 |
Ellenrieder, V | 2 |
Fensterer, H | 1 |
Waurick, M | 1 |
Adler, G | 2 |
Glasbrenner, B | 2 |
Kiel, G | 1 |
Korman, MG | 1 |
Bolin, TD | 1 |
Nicholson, FB | 1 |
Engelman, JL | 1 |
Adamsson, I | 2 |
Nord, CE | 2 |
Sjöstedt, S | 2 |
Wikström, B | 1 |
Seensalu, R | 1 |
Stack, WA | 1 |
Knifton, A | 1 |
Thirlwell, D | 1 |
Cockayne, A | 1 |
Jenkins, D | 1 |
Hawkey, CJ | 1 |
Atherton, JC | 1 |
Meier, E | 1 |
Casswall, TH | 1 |
Alfvén, G | 1 |
Drapinski, M | 1 |
Bergström, M | 1 |
Dahlström, KA | 1 |
Kirstein, FW | 2 |
Epple, HJ | 2 |
Bojarski, C | 2 |
Victor, L | 1 |
Fromm, M | 2 |
Riecken, EO | 2 |
Schulzke, JD | 2 |
Ritsuno, H | 1 |
Ohnuma, K | 1 |
Iinuma, K | 1 |
Asaka, M | 3 |
Dattilo, M | 1 |
Schultz-Süchting, F | 1 |
Stallmach, T | 2 |
Braegger, CP | 2 |
Tirén, U | 1 |
Sandstedt, B | 1 |
Finkel, Y | 1 |
Grimaz, S | 1 |
Damiani, D | 1 |
Brosolo, P | 1 |
Skert, C | 1 |
Geromin, A | 1 |
de Pretis, G | 1 |
Chen, W | 1 |
Shu, D | 1 |
Wilson, IR | 1 |
Tie, A | 1 |
Chadwick, VS | 1 |
Wustlich, S | 1 |
Brehler, R | 1 |
Luger, TA | 1 |
Pohle, T | 1 |
Foerster, E | 1 |
Yamasaki, K | 1 |
Takaishi, O | 1 |
Higuchi, K | 1 |
Kobayashi, K | 1 |
Kuroki, T | 1 |
Yamamoto, T | 2 |
Matsumoto, J | 1 |
Shiota, K | 1 |
Kitajima, S | 1 |
Goto, M | 1 |
Imaizumi, M | 1 |
Arima, T | 1 |
Michetti, P | 1 |
Dorta, G | 1 |
Wiesel, PH | 1 |
Brassart, D | 1 |
Herranz, M | 1 |
Felley, C | 1 |
Porta, N | 1 |
Rouvet, M | 1 |
Corthésy-Theulaz, I | 1 |
Abdul Aal, GM | 1 |
Dajani, AI | 1 |
Nounou, M | 1 |
Awad, S | 1 |
Abdul Rasheed, Z | 1 |
Gautam, S | 1 |
Ukabam, S | 1 |
Nayal, S | 1 |
Fortunato, A | 1 |
Rassu, M | 1 |
Meli, S | 1 |
Lombardo, L | 2 |
Masoero, G | 1 |
Della Monica, P | 1 |
Pera, A | 1 |
Mera, R | 1 |
Realpe, JL | 1 |
Bravo, LE | 1 |
DeLany, JP | 1 |
Correa, P | 1 |
Ali', A | 1 |
Menegatti, M | 1 |
Landi, F | 1 |
Acciardi, C | 1 |
Holton, J | 1 |
Dong, Q | 1 |
Komoto, K | 1 |
Mihara, M | 1 |
Chen, X | 1 |
Tahara, K | 1 |
Kawamura, Y | 1 |
Boeck, W | 1 |
Richter, C | 1 |
Marre, R | 1 |
Talley, NJ | 1 |
Vakil, N | 1 |
Ballard, ED | 1 |
Fennerty, MB | 1 |
Coyle, WJ | 1 |
Sedlack, RE | 1 |
Nemec, R | 1 |
Peterson, R | 1 |
Duntemann, T | 1 |
Murphy, M | 1 |
Lawson, JM | 1 |
Tanigawara, Y | 1 |
Shirakawa, K | 1 |
Komada, F | 1 |
Declich, P | 1 |
Ambrosiani, L | 1 |
Bellone, S | 1 |
Tavani, E | 1 |
Feldman, M | 1 |
Cryer, B | 1 |
Sammer, D | 1 |
Lee, E | 1 |
Spechler, SJ | 1 |
Nishikawa, K | 1 |
Ishizuka, J | 1 |
Kudo, T | 1 |
Komatsu, Y | 1 |
Katagiri, M | 1 |
Sukegawa, M | 1 |
Kagaya, H | 1 |
Kudo, M | 1 |
Kato, M | 1 |
Takeda, H | 1 |
Toyota, J | 1 |
García Pérez, A | 1 |
Valverde de La Osa, J | 1 |
Giménez Samper, M | 1 |
Alonso García, I | 1 |
Dillon, J | 1 |
Tildesley, G | 1 |
Wyatt, JI | 1 |
Gatz, G | 1 |
Braun, W | 1 |
Boixeda de Miquel, D | 1 |
Moreira Vicente, V | 1 |
Rollan, A | 1 |
Giancaspero, R | 1 |
Fuster, F | 1 |
Acevedo, C | 1 |
Figueroa, C | 1 |
Hola, K | 1 |
Schulz, M | 1 |
Duarte, I | 1 |
Fölsch, UR | 1 |
Hahn, EG | 1 |
von Kleist, DH | 1 |
Kirchner, T | 1 |
Strobel, S | 1 |
Kist, M | 1 |
Aydin, A | 1 |
Ersöz, G | 1 |
Tekesin, O | 1 |
Akçiçek, E | 1 |
Tuncyürek, M | 1 |
Georgopoulos, SD | 1 |
Ladas, SD | 1 |
Karatapanis, S | 1 |
Mentis, A | 1 |
Spiliadi, C | 1 |
Artikis, V | 1 |
Raptis, SA | 1 |
Shamaly, H | 1 |
Berkowitz, D | 1 |
Rosenthal, E | 1 |
Naveh, Y | 1 |
Nelis, F | 1 |
Mitchell, B | 1 |
Prichard, P | 1 |
Lloyd, D | 1 |
Frame, MH | 1 |
Romàn, J | 1 |
Shashidhar, H | 1 |
Peters, J | 1 |
Lin, CH | 1 |
Rabah, R | 1 |
Thomas, R | 1 |
Tolia, V | 1 |
Markert, M | 1 |
Crabtree, JE | 1 |
Bisson, S | 1 |
Edlund, C | 1 |
Jakić-Razumović, J | 1 |
Tentor, D | 1 |
Kusec, V | 1 |
Cuzić, S | 1 |
Brkić, T | 1 |
Vukobrat-Bijedić, Z | 1 |
Lacević, N | 1 |
Bratović, I | 1 |
Gribajcević, M | 1 |
Gogov, B | 1 |
Radović, S | 1 |
Konno, M | 1 |
Muraoka, S | 1 |
Takahashi, M | 1 |
Imai, T | 1 |
Slomiany, BL | 2 |
Piotrowski, J | 2 |
Slomiany, A | 2 |
Pace, F | 1 |
Mowat, C | 1 |
Williams, C | 1 |
Hossack, M | 1 |
Gilmour, D | 1 |
Carswell, A | 1 |
Wirz, A | 1 |
Preston, T | 1 |
Catalano, F | 1 |
Catanzaro, R | 1 |
Branciforte, G | 1 |
Bentivegna, C | 1 |
Cipolla, R | 1 |
Brogna, A | 1 |
Nuciforo, G | 1 |
Yamamoto, S | 1 |
Matsumura, N | 1 |
Frank, F | 1 |
Stricker, T | 1 |
Giannini, E | 1 |
Romagnoli, P | 1 |
Fasoli, A | 1 |
Chiarbonello, B | 1 |
Malfatti, F | 1 |
Botta, F | 1 |
Risso, D | 1 |
Lantieri, PB | 1 |
Savarino, V | 1 |
Testa, R | 1 |
Cacoub, P | 1 |
Sbaï, A | 1 |
Costedoat-Chalumeau, N | 1 |
Bellanger, J | 1 |
Godeau, P | 1 |
Piette, JC | 1 |
Perrucci, V | 1 |
Morra, I | 1 |
Gaido, F | 1 |
Ansaldi, N | 1 |
Hirschowitz, BI | 1 |
Haber, MM | 1 |
Befrits, R | 1 |
Odman, B | 1 |
Sörngård, H | 1 |
Lindberg, G | 1 |
Moayyedi, P | 1 |
Wason, C | 1 |
Peacock, R | 1 |
Bardhan, K | 1 |
de Luis, DA | 1 |
Cordero, JM | 1 |
Caballero, C | 1 |
Aller, R | 1 |
Cantón, R | 1 |
de la Calle, H | 1 |
Nomura, H | 1 |
Miyake, K | 1 |
Kashiwagi, S | 1 |
Festa, V | 1 |
Clemente, R | 1 |
Villani, MR | 1 |
Quitadamo, M | 1 |
Caruso, N | 1 |
Bergoli, ML | 1 |
Andriulli, A | 1 |
Rathi, P | 1 |
Sawant, P | 1 |
Gopanpallikar, A | 1 |
Carratù, R | 1 |
Iuliano, D | 1 |
Iovene, MR | 1 |
Ferraraccio, F | 1 |
Esposito, P | 1 |
Russo, MI | 1 |
Montella, F | 1 |
Abbate, G | 1 |
Tufano, MA | 1 |
Cherian, P | 1 |
Romanska, H | 1 |
Perry, MJ | 1 |
Schneider, A | 1 |
Fischer, R | 1 |
Ng, W | 1 |
Lühmann, R | 1 |
Ohara, T | 1 |
Goshi, S | 1 |
Taneike, I | 1 |
Tamura, Y | 1 |
Zhang, HM | 1 |
Toyoda, H | 1 |
Yamaguchi, M | 1 |
Nakamura, S | 1 |
Nakamura, T | 1 |
Kimura, M | 1 |
Mukai, K | 1 |
Sawa, H | 1 |
Kawamura, K | 1 |
Shiku, H | 1 |
Ashorn, M | 1 |
Ruuska, T | 1 |
Mäkipernaa, A | 1 |
Cicconi, V | 1 |
Carloni, E | 1 |
Franceschi, F | 1 |
Nocente, R | 1 |
Silveri, NG | 1 |
Manna, R | 1 |
Servidei, S | 1 |
Bentivoglio, AR | 1 |
Plein, K | 1 |
Hotz, J | 1 |
Grigor'ev, PIa | 1 |
Iakovenko, EP | 1 |
Talanova, EV | 1 |
Tankovic, J | 1 |
Lamarque, D | 1 |
Lascols, C | 1 |
Soussy, CJ | 1 |
Delchier, JC | 1 |
Geboes, K | 1 |
Dekker, W | 1 |
Mulder, CJ | 1 |
Nusteling, K | 1 |
Vichev, E | 1 |
Krŭstev, N | 1 |
Krŭstev, D | 1 |
Baeva, N | 1 |
Kiselova, A | 1 |
Ianev, N | 1 |
Vieth, M | 1 |
Gottrand, F | 1 |
Kalach, N | 1 |
Spyckerelle, C | 1 |
Guimber, D | 1 |
Mougenot, JF | 1 |
Tounian, P | 1 |
Lenaerts, C | 1 |
Roquelaure, B | 1 |
Lachaux, A | 1 |
Morali, A | 1 |
Dupont, C | 1 |
Maurage, C | 1 |
Husson, MO | 1 |
Barthélemy, P | 1 |
Zavros, Y | 2 |
Rieder, G | 2 |
Ferguson, A | 2 |
Samuelson, LC | 2 |
Merchant, JL | 2 |
Röbbecke, J | 1 |
Dojo, M | 1 |
Azuma, T | 1 |
Saito, T | 1 |
Ohtani, M | 1 |
Muramatsu, A | 1 |
Kuriyama, M | 1 |
Martínez-Chamorro, C | 1 |
Martínez, E | 1 |
Gil-Fernández, JJ | 1 |
Escudero, A | 1 |
Acevedo, A | 1 |
Fernández-Rañada, JM | 1 |
Treiber, G | 2 |
Wittig, J | 1 |
Ammon, S | 1 |
Walker, S | 2 |
van Doorn, LJ | 1 |
Klotz, U | 2 |
Koçkar, C | 1 |
Oztürk, M | 1 |
Bavbek, N | 1 |
Kirsch, C | 1 |
Dragosics, B | 1 |
Gschwantler, M | 1 |
Oberhuber, G | 1 |
Antos, D | 1 |
Dite, P | 1 |
Läuter, J | 1 |
Leodolter, A | 2 |
Schilling, D | 1 |
Messerer, P | 1 |
Ott, MG | 1 |
Schauwecker, P | 1 |
Zober, A | 1 |
Riemann, JF | 1 |
Zullo, A | 1 |
Hassan, C | 1 |
Lorenzetti, R | 1 |
Morini, S | 1 |
Kitahora, T | 1 |
Miyazawa, M | 1 |
Nagahashi, S | 1 |
Suzuki, K | 1 |
Yoshinaga, M | 1 |
Ohtani, A | 1 |
Harada, N | 1 |
Fukuda, Y | 1 |
Nawata, H | 1 |
Baena, JM | 1 |
López, C | 1 |
Hidalgo, A | 1 |
Rams, F | 1 |
Jiménez, S | 1 |
García, M | 1 |
Hernández, MR | 1 |
Isomoto, H | 1 |
Kohno, S | 1 |
Suzuki, T | 1 |
Ohara, S | 1 |
Noguchi, K | 1 |
Sekine, H | 1 |
Nagura, H | 1 |
Shimosegawa, T | 1 |
Gotoh, A | 1 |
Shimizu, T | 1 |
Shimodaira, K | 1 |
Kaneko, T | 1 |
Kiyosawa, K | 1 |
Ishida, K | 1 |
Ikeno, T | 1 |
Sugiyama, A | 1 |
Kawakami, Y | 1 |
Katsuyama, T | 1 |
Knippig, C | 1 |
Arand, F | 1 |
Nilius, M | 1 |
Klein, U | 1 |
Ozdemir, A | 1 |
Mas, MR | 1 |
Sahin, S | 1 |
Sağlamkaya, U | 1 |
Ateşkan, U | 1 |
Bertschinger, P | 1 |
Brunner, J | 1 |
Flury, R | 1 |
Lammer, F | 1 |
Jost, R | 1 |
Häcki, WH | 1 |
Gyenes, E | 3 |
Rühl, GH | 2 |
Sherman, P | 1 |
Shames, B | 1 |
Loo, V | 1 |
Matlow, A | 1 |
Drumm, B | 1 |
Penner, J | 1 |
Vaara, M | 1 |
Renkonen, OV | 1 |
Tsuneoka, K | 1 |
Gail, K | 1 |
Mihaljevic, L | 1 |
Varrentrapp, M | 1 |
Lange, P | 1 |
Müller, MJ | 1 |
Schorn, T | 1 |
Soudah, B | 1 |
Bär, W | 1 |
Gebel, M | 1 |
Daw, MA | 1 |
Deegan, P | 1 |
Leen, E | 1 |
Koop, H | 1 |
Stumpf, M | 1 |
Stöckmann, F | 1 |
Di Girolamo, A | 1 |
Jenkins, CC | 1 |
DeNovo, RC | 1 |
Patton, CS | 1 |
Bright, RM | 1 |
Rohrbach, BW | 1 |
Sarem-Aslani, A | 1 |
Bode, JC | 1 |
Hui, WM | 1 |
Ho, J | 1 |
Lai, CL | 1 |
Lok, AS | 1 |
Ng, MM | 1 |
Lau, WY | 1 |
Branicki, FJ | 1 |
Beglinger, C | 1 |
Bethke, B | 1 |
Darchis, I | 1 |
Colombel, JF | 1 |
Janin, A | 1 |
Collet, R | 1 |
Wallaert, B | 1 |
Cortot, A | 1 |
Collier, DS | 1 |
Crampton, J | 1 |
Everett, WG | 1 |
di Febo, G | 1 |
Gad, A | 1 |
Gnarpe, H | 1 |
Olsson, J | 1 |
Bank, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047] | Phase 2/Phase 3 | 138 participants | Interventional | 2006-01-31 | Recruiting | ||
Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication[NCT03650543] | Phase 4 | 133 participants (Actual) | Interventional | 2012-09-10 | Completed | ||
the Effect of Daily Use of Proton Pump Inhibitors for One Month on Renal Function[NCT03910647] | Phase 2 | 200 participants (Anticipated) | Interventional | 2019-12-31 | Not yet recruiting | ||
Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05802888] | Phase 4 | 260 participants (Anticipated) | Interventional | 2023-03-12 | Recruiting | ||
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.[NCT05431075] | Phase 4 | 407 participants (Anticipated) | Interventional | 2022-07-31 | Not yet recruiting | ||
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy: A Multicenter Randomized Non-Inferiority Trial of Different Tetracycline Doses and Frequencies.[NCT05432115] | Phase 4 | 407 participants (Anticipated) | Interventional | 2022-06-25 | Recruiting | ||
European Registry on the Management of Helicobacter Pylori Infection[NCT02328131] | 10,000 participants (Anticipated) | Observational | 2013-06-30 | Recruiting | |||
Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori[NCT00149084] | Phase 3 | 296 participants | Interventional | 2003-04-30 | Recruiting | ||
Phase 4, Prospective, Randomized and Comparative Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice[NCT01273441] | Phase 4 | 338 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection[NCT00656968] | Phase 4 | 232 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
Dyspeptic Symptoms Evolution After Eradication of Helicobacter Pylori in Patients With Different Endoscopic Findings: a Randomized Double-blind Placebo-controlled Clinical Trial With 12 Months of Follow-up[NCT00404534] | Phase 3 | 407 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
Treatment of Low-Grade Gastric Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)[NCT00154440] | Phase 3 | 200 participants | Interventional | 2001-11-30 | Recruiting | ||
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757] | 48 participants (Anticipated) | Interventional | 2012-03-31 | Not yet recruiting | |||
Effectiveness of Rifabutin Triple Therapy for First-line and Rescue Treatment of Helicobacter Pylori Infection[NCT04652284] | Phase 3 | 300 participants (Anticipated) | Interventional | 2021-05-01 | Not yet recruiting | ||
Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori[NCT05957432] | Phase 2 | 90 participants (Anticipated) | Interventional | 2023-07-15 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT00656968)
Timeframe: one month after finishing study drugs
Intervention | participants (Number) |
---|---|
Concomitant Therapy (A) | 92 |
Sequential Therapy (B) | 95 |
Good drug compliance is defined as taking equal to or more than 80% of eradication medicines (NCT00656968)
Timeframe: one month after finishing test therapy
Intervention | participants (Number) |
---|---|
Concomitant Therapy (A) | 106 |
Sequential Therapy (B) | 104 |
26 reviews available for omeprazole and Gastritis
Article | Year |
---|---|
The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis.
Topics: Atropine; Gastritis; Humans; Omeprazole; Treatment Outcome | 2021 |
Gastric MALT lymphoma and Helicobacter pylori.
Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Ther | 2019 |
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combinati | 2002 |
Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.
Topics: Age Factors; Barrett Esophagus; Female; Gastric Acid; Gastritis; Gastroesophageal Reflux; Gastrointe | 2003 |
[The treatment of Helicobacter pylori infection in upper gastrointestinal disorders].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Dyspepsia; Gastritis; Gastrointes | 2003 |
[Eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, | 2005 |
[Proton pump inhibitors in developmental period medicine].
Topics: Adult; Age Factors; Anti-Ulcer Agents; Child; Drug Interactions; Duodenitis; Enzyme Inhibitors; Esom | 2007 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis | 1995 |
[How to use proton pump inhibitors and histamine H2 antagonists in the therapy of peptic ulcer].
Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazol | 1995 |
Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Topics: Animals; Carcinoid Tumor; Enterochromaffin Cells; Gastric Acid; Gastric Mucosa; Gastrins; Gastritis; | 1993 |
Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Gastroesophag | 1993 |
Omeprazole, Helicobacter pylori, and gastritis.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicoba | 1994 |
[Omeprazole treatment and fever].
Topics: Aged; Aged, 80 and over; Fever; Gastritis; Hernia, Hiatal; Humans; Male; Omeprazole | 1994 |
The role of acid inhibition in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric | 1994 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helic | 1994 |
Emerging strategies for managing peptic ulcer disease.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Depression, Chemical; Drug Therapy, Combinatio | 1994 |
[Current therapy of Helicobacter pylori infection].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infe | 1994 |
[Diagnosis and treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Dr | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Micro | 1996 |
Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Topics: Anti-Ulcer Agents; Atrophy; Gastric Acid; Gastric Mucosa; Gastritis; Gastroesophageal Reflux; Helico | 1997 |
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials a | 1998 |
Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; C | 1998 |
[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Topics: Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Esophageal Diseases; Esophagitis; Gastritis; | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; | 2000 |
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclospo | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combina | 2002 |
144 trials available for omeprazole and Gastritis
Article | Year |
---|---|
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicob | 2017 |
Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Female; Gastritis; Heli | 2013 |
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Drug The | 2013 |
Ten-day bismuth-containing quadruple therapy is effective as first-line therapy for Helicobacter pylori-related chronic gastritis: a prospective randomized study in China.
Topics: Adult; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobact | 2017 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2009 |
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Sc | 2009 |
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; | 2010 |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; C | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; C | 2011 |
Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Creatinine; Dose-Response | 2011 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug T | 2002 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2002 |
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti | 2002 |
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2003 |
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; E | 2003 |
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Analysis of Variance; Anti-Ulcer Agents; Benzi | 2003 |
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Disease Progression; Double- | 2004 |
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
Topics: Adenocarcinoma; Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastritis; Helicobacter Infec | 2004 |
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective A | 2004 |
Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Esomeprazole; Female; Follow-Up Stud | 2004 |
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind | 2004 |
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; | 2004 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedu | 2004 |
Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum.
Topics: Anti-Ulcer Agents; DNA Adducts; DNA Damage; Esophageal Diseases; Esophagogastric Junction; Female; G | 2004 |
Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agent | 2005 |
Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedu | 2005 |
Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; | 2005 |
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Dis | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromyc | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal | 2005 |
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2006 |
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; D | 2006 |
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Co | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benz | 2006 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; | 2005 |
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents | 2006 |
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.
Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Gastric Acid; Gastritis; Goiter; Helicobacter Infec | 2006 |
Furazolidone-based triple therapy for H pylori gastritis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2006 |
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Presc | 2007 |
[Age and eradication treatment of duodenal ulcer].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Combinations; | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; | 2007 |
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Co | 2008 |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dose-Response | 2008 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; | 1995 |
The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-B | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 1995 |
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Clarithromyc | 1995 |
Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin.
Topics: Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow | 1995 |
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric | 1995 |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinatio | 1995 |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
Topics: Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Hel | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.
Topics: Adult; Age Factors; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gast | 1994 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer | 1995 |
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; | 1994 |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Female; Gastritis; Helicobacter | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastrit | 1994 |
Lansoprazole and Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; | 1993 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Du | 1996 |
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastric Acidity Determination; | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1996 |
Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Co | 1996 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ul | 1996 |
Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Diarrhea; Double-Blind Method; Enzyme Inhibitors; Esophagit | 1996 |
Effect of omeprazole on Helicobacter pylori urease activity in vivo.
Topics: Adult; Aged; Enzyme Inhibitors; Female; Gastritis; Helicobacter pylori; Humans; Male; Middle Aged; O | 1996 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Dr | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cross-Over Studies; Diagnosis, Diffe | 1997 |
An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastriti | 1997 |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; C | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti | 1997 |
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; | 1997 |
Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.
Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter I | 1997 |
Parietal cell protrusions in gastric ulcer disease.
Topics: Chronic Disease; Double-Blind Method; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helico | 1997 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diar | 1996 |
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug The | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; D | 1996 |
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; C | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Age | 1997 |
Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship | 1997 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double | 1998 |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug | 1996 |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsi | 1998 |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administrat | 1998 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1998 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gas | 1998 |
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1998 |
The value of different detection methods of Helicobacter pylori during treatment.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteriological Techniques; Biopsy; Drug Administration | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromy | 1998 |
Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response | 1998 |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1998 |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithr | 1999 |
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Ga | 1999 |
Helicobacter pylori as a possible bacterial focus of chronic urticaria.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Female; Gastritis | 1999 |
Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bacterial Adhesion; Breath Tests; Colony Count, Micr | 1999 |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Cla | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial | 1999 |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Do | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; C | 1999 |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Et | 1999 |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinat | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 1999 |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Cla | 1999 |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1999 |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidaz | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul | 2000 |
Garlic oil and Helicobacter pylori infection.
Topics: Adult; Allyl Compounds; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Disulfides; Dyspe | 2000 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2000 |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biop | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose- | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2000 |
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2000 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Famotidine; Gastric Mucosa; Gastritis; Gastroscopy; Helicobact | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles | 2000 |
Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, C | 2000 |
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dr | 2000 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Ant | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidaz | 2001 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Th | 2000 |
Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath T | 2001 |
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Administration Schedule; Endoscopy; Enzyme Inhib | 2001 |
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastr | 2001 |
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimid | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2002 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2001 |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointe | 2001 |
Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Biopsy; | 2002 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 2002 |
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2002 |
[Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study].
Topics: Antacids; Breath Tests; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helic | 1992 |
Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
Topics: Amoxicillin; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, C | 1992 |
[Short-term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication. A pilot study].
Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combinati | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 1991 |
Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment.
Topics: Drug Combinations; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; | 1991 |
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori.
Topics: Adult; Chronic Disease; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helicobacter Infecti | 1991 |
Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.
Topics: Adult; Amoxicillin; Campylobacter Infections; Double-Blind Method; Drug Therapy, Combination; Female | 1989 |
218 other studies available for omeprazole and Gastritis
Article | Year |
---|---|
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infec | 2022 |
Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial P | 2020 |
Protective Effects of Wheat Peptides against Ethanol-Induced Gastric Mucosal Lesions in Rats: Vasodilation and Anti-Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dinoprostone; Disease Models, Animal; Endothelin-1; Et | 2020 |
Luetic gastritis: an uncommon cause of gastritis.
Topics: Abdominal Pain; Adult; Gastritis; Humans; Nausea; Omeprazole; Vomiting | 2020 |
The effect of Astragaloside IV on ethanol-induced gastric mucosal injury in rats: Involvement of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Ethanol; Gast | 2017 |
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera
Topics: Adult; Aged; Breath Tests; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Fema | 2018 |
Effects of the administration of aqueous extract of de Sedum dendroideum on the histopathology of erosive induced gastritis by means of indomethacin in rats.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cyclooxygenase Inhibitors; Gastric Mucosa; Gastritis; Ind | 2014 |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Dis | 2014 |
Star gazing in a dog: atypical manifestation of upper gastrointestinal disease.
Topics: Animals; Diagnosis, Differential; Dog Diseases; Dogs; Female; Gastritis; Omeprazole; Stereotyped Beh | 2014 |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter I | 2014 |
Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models.
Topics: Animals; Anti-Ulcer Agents; Gastritis; Gastrointestinal Hemorrhage; Hemostatics; Male; Omeprazole; P | 2016 |
Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Catalase; Clostridium butyricum; Cold Temperature; Disease Mo | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combin | 2015 |
Successful Treatment of Early-Diagnosed Primary Phlegmonous Gastritis.
Topics: Anti-Bacterial Agents; Cellulitis; Endoscopy, Digestive System; Gastritis; Humans; Male; Meropenem; | 2015 |
[Palpable purpura with severe pruritus].
Topics: Aged; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastr | 2008 |
Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
Topics: Animals; Bombesin; Disease Models, Animal; Gastric Mucosa; Gastritis; Indomethacin; Lipid Peroxidati | 2009 |
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Comb | 2009 |
Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Dose-Response Relationship, Drug; Drug Admi | 2010 |
Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.
Topics: Ammonium Chloride; Animals; Anti-Ulcer Agents; Antioxidants; Cell Death; Cells, Cultured; Communicab | 2010 |
Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Citrus; Coumari | 2010 |
Iatrogenic gastric wall abscess infected with Enterobacter cloacae after biopsy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Comb | 2010 |
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Di | 2011 |
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobac | 2011 |
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial P | 2012 |
An unusual referral for epigastric pain, nausea, abdominal bloating, diarrhea, and weight loss.
Topics: Abdominal Pain; Adult; Anti-Ulcer Agents; Biopsy; Celiac Disease; Diarrhea; Diet, Gluten-Free; Duode | 2012 |
Osteoporosis with underlying connective tissue disease: an unusual case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant | 2002 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combinat | 2002 |
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Cla | 2002 |
[A case for proton pump blocker... When cough comes from the stomach].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age | 2002 |
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.
Topics: Adult; Anti-Ulcer Agents; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; M | 2003 |
Helicobacter pylori hiccup.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinat | 2003 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug The | 2003 |
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in Turkish children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Gastritis; Helicobacter Infections; Heli | 2003 |
[Inmediate antphylactic shock after the administration of intravenous omeprazol].
Topics: Aged; Anaphylaxis; Anti-Ulcer Agents; Female; Gastritis; Heart Arrest; Humans; Injections, Intraveno | 2003 |
Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Follow-Up Studies; Gastric Mucosa; Gastr | 2002 |
Complications of medical management of dental erosion.
Topics: Adult; Enzyme Inhibitors; Gastritis; Gastroesophageal Reflux; Humans; Male; Omeprazole; Proton Pump | 2003 |
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2003 |
Nodular gastritis in adults is caused by Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy, Needle; Case-Control Studies; Cohort Studies | 2003 |
Omeprazole reduces clozapine plasma concentrations. A case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP1A2; Drug Antagonism; Esophagitis; Femal | 2003 |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; C | 2003 |
Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Topics: Achlorhydria; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cell Division; Drug Administration Schedul | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Com | 2003 |
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endosco | 2003 |
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Fasting; Female; Gastric Acid; Gastric Mucosa; Gast | 2004 |
Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?
Topics: Abdominal Pain; Anti-Ulcer Agents; Dyspepsia; Gastritis; Gastroesophageal Reflux; Helicobacter Infec | 2004 |
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; | 2004 |
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; D | 2004 |
[Chronic upper abdominal pain without improvement after using proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Ulcer Agents; Azathioprine; Duodenal U | 2004 |
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydroge | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Mic | 2004 |
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combi | 2004 |
Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Cyclooxygenase 2; Female; Follow-Up Studies; G | 2004 |
Acute colchicine intoxication during clarithromycin administration.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colchicine; Drug Intera | 2004 |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 2004 |
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count; | 2005 |
The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Breath Tests; Carbon Isotopes; Enzyme Inhibitors; Fem | 2005 |
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Age | 2005 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents | 2005 |
The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apigenin; Clerodendrum; Dose-Re | 2005 |
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithrom | 2005 |
Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Arte | 2005 |
Omeprazole-induced hepatitis.
Topics: Adolescent; Anti-Ulcer Agents; Chemical and Drug Induced Liver Injury; Female; Gastritis; Humans; Om | 2005 |
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin; | 2005 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2006 |
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents | 2005 |
Gastric pH, sevelamer hydrochloride and omeprazole.
Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Interactions; Fema | 2005 |
Anaphylaxis to omeprazole: diagnosis and desensitization protocol.
Topics: Adult; Anaphylaxis; Desensitization, Immunologic; Enzyme Inhibitors; Gastritis; Helicobacter Infecti | 2006 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer | 2005 |
The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats.
Topics: Animals; Antioxidants; Dose-Response Relationship, Drug; Esophagitis, Peptic; Gastric Acid; Gastric | 2006 |
Thyroxine in goiter, H. pylori infection, and gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adsorption; Anti-Ulcer Agents; Benzimidazoles; Biological A | 2006 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; D | 2006 |
[Antihelicobacter effects of melatonin].
Topics: Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter | 2007 |
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Aci | 2007 |
[Evidence based treatment strategy for dyspeptic symptoms].
Topics: Dyspepsia; Evidence-Based Medicine; Gastritis; Histamine H2 Antagonists; Humans; Omeprazole; Proton | 2007 |
Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Biopsy; Child; Collagen; Collagen Diseas | 2007 |
Effect of some natural products either alone or in combination on gastritis induced in experimental rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Curcuma; Disease Models, Animal; Fatty Acids, O | 2008 |
Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helico | 1995 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combinat | 1995 |
Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
Topics: Adolescent; Adult; Age Distribution; Aged; Antacids; Child; Child, Preschool; Drug Prescriptions; Dr | 1995 |
Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats.
Topics: Animals; Ethanol; Gastric Acid; Gastric Mucosa; Gastritis; Hydrochloric Acid; Male; Misoprostol; Muc | 1995 |
[Progress on therapy of peptic ulcer (discussion)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Gastritis; Helicobacter Infections; Helicobacter pylori; Hi | 1995 |
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Topics: Antacids; Biopsy; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Gastritis, Atrophi | 1995 |
[Therapy of Helicobacter pylori associated diseases].
Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combinati | 1995 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy | 1995 |
Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels.
Topics: Adult; Carbamazepine; Clarithromycin; Drug Interactions; Gastritis; Helicobacter Infections; Helicob | 1995 |
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Female; Follow-Up Studies; Gastritis; Helicobacter Infe | 1995 |
[Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Female; Follo | 1995 |
Esophageal candidiasis following omeprazole therapy: a report of two cases.
Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto | 1995 |
Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
Topics: Anti-Ulcer Agents; Bacterial Adhesion; Carcinoma; Cells, Cultured; Cimetidine; Duodenal Ulcer; Epith | 1994 |
Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
Topics: Abdominal Pain; Adolescent; Child; Chronic Disease; Drug Resistance; Esophagitis, Peptic; Gastritis; | 1995 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter I | 1994 |
Haemorrhagic gastritis in two patients treated with all-trans-retinoic acid in acute promyelocytic leukaemia.
Topics: Aged; Female; Gastritis; Gastrointestinal Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male; | 1994 |
[Reversible thrombocytopenia due to digitoxin overdose].
Topics: Aged; Digitoxin; Drug Overdose; Female; Gastritis; Gastroscopy; Heart Failure; Humans; Nausea; Omepr | 1994 |
Helicobacter pylori: a fickle germ.
Topics: Aerobiosis; Culture Media; False Negative Reactions; Gastritis; Helicobacter Infections; Helicobacte | 1994 |
Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination | 1994 |
Healing gastric MALT lymphomas by eradicating H pylori?
Topics: Amoxicillin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymp | 1993 |
Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects.
Topics: Achlorhydria; Aged; Bacteria; Carbohydrates; Colony-Forming Units Assay; Fats; Feces; Female; Gastri | 1994 |
[New development on the study of etiological pathology of gastritis, peptic ulcer and stomach cancers in relationship to Helicobacter pylori infection].
Topics: Antibodies, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1993 |
[The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis].
Topics: Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middl | 1993 |
One-day therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy, | 1993 |
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Division; Female; Gastrins; Gastritis; Helicobacter | 1993 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; G | 1995 |
Azithromycin for the cure of Helicobacter pylori infection.
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combina | 1996 |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Carbamazepine; Clarithromycin; Drug Interactions; Drug The | 1996 |
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; D | 1996 |
Italian omeprazole triple therapy--a 1-week regimen.
Topics: Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter | 1996 |
Inhibition of Helicobacter pylori by garlic extract (Allium sativum).
Topics: Anti-Bacterial Agents; Duodenal Ulcer; Enzyme Inhibitors; Garlic; Gastritis; Helicobacter Infections | 1996 |
Helicobacter pylori and lanzoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Duodenal Ulcer; Gastritis; Helicobacter | 1996 |
Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole.
Topics: Adult; Duodenitis; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Intest | 1996 |
Etiological involvement of Helicobacter pylori in "reflux" gastritis after gastrectomy.
Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Drug Therapy, Combination; Female; Gastric Muco | 1996 |
[Association of chronic urticaria with Helicobacter pylori-induced antrum gastritis].
Topics: Adult; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infe | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Anim | 1996 |
Atopic dermatitis successfully treated by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Blott | 1996 |
Helicobacter pylori, gastric ulcer, and duodenal ulcer.
Topics: Age of Onset; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omepr | 1996 |
[Meta-analysis raises more questions, than it answers].
Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal | 1996 |
[Meta-analyses are hardly suitable for conclusively proving medical controversies].
Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal | 1996 |
[Meta-analysis should be regarded with extreme caution].
Topics: Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Anal | 1996 |
[Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administra | 1996 |
Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis.
Topics: Adult; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastrins; Gastritis; Gastroscopy; Helicobacter Inf | 1996 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug T | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; D | 1996 |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin | 1997 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug T | 1997 |
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Female; Gastric Mucosa; Gastrins; Gastritis; H | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter I | 1996 |
Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Eruptions; Drug Therapy, Combination; Fe | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarke | 1997 |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; D | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gast | 1997 |
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amoxicillin; Anti-Ulcer Agents; Disease-Free Su | 1997 |
A prospective follow-up study of 5669 users of lansoprazole in daily practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agen | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resist | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esop | 1997 |
Successful treatment of protein-losing lymphocytic gastritis with omeprazole.
Topics: Aged; Female; Gastric Mucosa; Gastritis; Humans; Lymphocytes; Omeprazole | 1997 |
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Epithelial C | 1997 |
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; D | 1998 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therap | 1998 |
Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia?
Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Female; Gastric Empty | 1997 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combinati | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Dru | 1998 |
The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease.
Topics: Aged; Aging; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; | 1998 |
Effect of Helicobacter pylori infection on gastric juice pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studi | 1998 |
A study on the relation between proton pump inhibitor and gastric giardiasis.
Topics: Adult; Animals; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastritis; Giardia lamblia; Giardiasis; H | 1998 |
Weekend therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Sc | 1998 |
Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Chem | 1998 |
[Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study].
Topics: Adult; Aged; Anti-Ulcer Agents; Biopsy; Chronic Disease; Esophagitis, Peptic; Female; Follow-Up Stud | 1998 |
Omeprazole efficacy and Helicobacter pylori infection.
Topics: Anti-Ulcer Agents; Dose-Response Relationship, Drug; Gastric Acid; Gastritis; Helicobacter Infection | 1998 |
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis.
Topics: Adult; Aged; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Muc | 1998 |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; | 1998 |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; H | 1998 |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Granul | 1999 |
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helic | 1999 |
Does Helicobacter pylori affect the management of gastroesophageal reflux disease?
Topics: Enzyme Inhibitors; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; | 1999 |
Influence of rebamipide on indometacin-induced gastric hemorrhage in rats under restraint stress.
Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Catalas | 1999 |
Helicobacter heilmannii associated erosive gastritis.
Topics: Abietanes; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endoscopy, D | 1999 |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multipl | 1999 |
[Effect of Helicobacter pylori on gastric epithelial apoptosis].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Apoptosis; Drug Therapy, Combination; Epithel | 1997 |
Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Chronic Disease; Drug Th | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bism | 1999 |
Corpus-active gastritis with focal atrophy and parietal cell hyperplasia related to long-term use of omeprazole.
Topics: Atrophy; Gastritis; Humans; Hyperplasia; Omeprazole; Parietal Cells, Gastric; Stomach; Time Factors | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Fema | 1999 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, | 2000 |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Fe | 2000 |
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Child; Drug Resist | 2000 |
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.
Topics: Adult; Ammonia; Anti-Ulcer Agents; Female; Follow-Up Studies; Gastric Acidity Determination; Gastrit | 2000 |
Histopathological features of gastritis before and after treatment for Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infection | 2000 |
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; | 2000 |
Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Apoptosis; Endothelin-1; Gastric Mucosa; Gastritis; Helic | 2000 |
Should we eradicate Helicobacter pylori in patients with recurrent gastro-oesophageal reflux disease?
Topics: Esophagitis; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Human | 2000 |
Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.
Topics: Adult; Anti-Ulcer Agents; Ascorbic Acid; Female; Gastric Juice; Gastritis; Helicobacter Infections; | 2000 |
Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Drug Administration Schedule; Esophageal Neoplasms; Esophagiti | 2000 |
Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide.
Topics: Animals; Anti-Ulcer Agents; Aspartic Acid Endopeptidases; Endothelin-Converting Enzymes; Gastric Muc | 2000 |
Helicobacter pylori infection in recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; C | 2000 |
[Edematous syndrome revealing an exudative lymphocytic gastritis: efficacy of omeprazole].
Topics: Abdominal Pain; Anti-Ulcer Agents; Edema; Exudates and Transudates; Female; Gastritis; Humans; Lymph | 2000 |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Bacterial | 2000 |
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Enterochromaffin-like Cells; Enzyme Inhibitors; Fema | 2001 |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, T | 2001 |
Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Diseas | 2001 |
Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cell Division; Clarithromycin; Dose-Respons | 2001 |
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Comm | 2001 |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Heli | 2001 |
Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, | 2001 |
[The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Chronic Disease | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru | 2001 |
Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chronic Disease; Dyspepsia; Gastritis; Helicobacter Infecti | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
Fundic gland polyps are not induced by proton pump inhibitor therapy.
Topics: Enzyme Inhibitors; Female; Gastric Fundus; Gastritis; Helicobacter Infections; Helicobacter pylori; | 2001 |
Hypergastrinemia in response to gastric inflammation suppresses somatostatin.
Topics: Animals; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Fundus; Gastric Mucosa; Gastrins; Gastriti | 2002 |
Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice.
Topics: Achlorhydria; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; B-Lymphocytes; Bacteriological Tech | 2002 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; | 2002 |
Helicobacter pylori eradication: do we have another ace up our sleeve?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Infective Agents; Be | 2001 |
Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy.
Topics: Acids; Anti-Ulcer Agents; Ascorbic Acid; Drug Therapy, Combination; Female; Gastritis; Helicobacter | 2001 |
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clari | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; D | 2002 |
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarith | 2001 |
Omeprazole therapy for Helicobacter pylori infection.
Topics: Adolescent; Adult; Child; DNA Fingerprinting; Duodenal Ulcer; Female; Gastritis; Helicobacter Infect | 1992 |
In vitro activity of antifungal azoles against Helicobacter pylori.
Topics: Antifungal Agents; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Test | 1992 |
[Peptic ulcer and drug therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Ga | 1991 |
Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration.
Topics: Adult; Eosinophilia; Female; Gastritis; Gastroscopy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ra | 1991 |
Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis.
Topics: Adult; Aged; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle | 1991 |
Antral Helicobacter pylori-like organisms in different states of gastric acid secretion.
Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastric Acid; Gastritis; Helic | 1991 |
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
Topics: Administration, Oral; Animals; Aspirin; Cimetidine; Dog Diseases; Dogs; Double-Blind Method; Gastrit | 1991 |
[Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Campylobacter Infections; Ciprofloxacin; Drug | 1991 |
Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine.
Topics: Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Humans; Hydrogen-Ion Concentration; | 1991 |
[Current perspectives in ulcer disease].
Topics: Anti-Bacterial Agents; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Huma | 1990 |
Elimination of Helicobacter pylori under treatment with omeprazole.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; | 1990 |
[A case of protein-losing lymphocytic gastritis treated by omeprazole].
Topics: Adult; Blood Proteins; Female; Gastric Mucosa; Gastritis; Humans; Lymphocytes; Omeprazole | 1990 |
Acute haemorrhagic gastritis controlled by omeprazole.
Topics: Acute Disease; Gastritis; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole | 1989 |
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer.
Topics: Campylobacter; Campylobacter Infections; Duodenal Ulcer; Gastritis; Humans; Omeprazole | 1989 |
Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Critical Care; Gastri | 1985 |